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1 Introduction:  
1.1 Retina 
The vertebrate retina consists of several neuronal layers interconnected by synapses. From the 
vitreous side, the first neuronal layer is the ganglion cell layer (GCL) with the soma of retinal ganglion 
cells and aberrant amacrine cells. The axons of the retinal ganglion cells (RGC) form the optic nerve. 
The cells of the RGC layer are connected by synapses with the neurons of the inner nuclear layer 
(INL). Within the INL, there are several different neuronal populations: the amacrine, bipolar and 
horizontal cells. Additionally the cell somas of the Müller glia cells are located in the INL. The INL 
neurons are again interconnected by synapses with the light sensitive photoreceptor cells, their cell 
soma are located in the outer nuclear layer (ONL). Figure 1 shows a schematic of the retina and a 
corresponding semithin section of the retinal morphology. 
 
Figure 1: Morphology of the retina 
Schematic and corresponding semithin section of retinal morphology. Abbreviations: NFL: nerve fiber layer, 
GCL: ganglion cell layer, IPL: inner plexiform layer, INL: inner nuclear layer, OPL: outer plexiform layer, ONL: 
outer nuclear layer, RPE: retinal pigment epithelium. Slightly modified after (1), semithin section (right hand 
side) by Barbara Braunger. 
1.1.1 Retinal neurons and glia cells 
1.1.1.1 Retinal ganglion cells 
The retinal ganglion cells are located in the innermost neuronal layer of the retina. The axons of the 
retinal ganglion cells form the nerve fiber layer (stratum opticum) which is situated on top of the 
retinal ganglion cell soma, next to the side of the vitreous. These axons conjoin in the central retina 
as optic nerve head and form thereafter the optic nerve, which extend after the optic chiasm as optic 
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tract in the optic center of the brain (2). There are different subpopulations of retinal ganglion cells 
(3) that use different neurotransmitter gamma-aminobutyric acid (GABA), glycine or glutamate (4). 
The retinal ganglion cells have different functions, apart from sending photoreceptor derived signal 
into the optic center of the brain. For example, photosensitive retinal ganglion cell are involved in the 
pupillary reaction and circadian rhythm (5,6).  
1.1.1.2 The inner nuclear layer (INL):  
The inner nuclear layer (INL) is composed of various different cell types. One has to distinguish 
between neuronal cells like amacrine, bipolar and horizontal cells and Müller glia cells (see 1.1.1.4.). 
1.1.1.3 Neurons of the INL: amacrine cells, bipolar cells and horizontal cells  
Amacrine cells are located in the retinal ganglion cell layer, where they are called aberrant amacrine 
cells and in the inner aspect of the inner nuclear layer (2). There are various subtypes (> 30 different 
subtypes) of amacrine cells (7,8). Amacrine cells have large dendrites that extend laterally in the 
inner plexiform layer. They modulate ganglion cell function by utilizing inhibitory neurotransmitters 
like GABA or glycine, but also the excitatory neurotransmitter acetylcholine (9). Additionally, 
amacrine cells with extensive ramified dendrites are thought to support the function of horizontal 
cells by sending inhibitory feedback to bipolar cells and ganglion cells. 
Bipolar cells are the major neuronal cell population in the inner nuclear layer (2). They are 
interneurons, transporting the signals from the photoreceptor cells to the ganglion cells. One 
distinguishes between cone and rod bipolar cells and the way they mediate the electric excitation as 
on- and off-bipolar cells (10). In the mouse retina, there is one class of rod driven bipolar cell and 11 
subtypes of cone driven bipolar cells (11). Bipolar cells use the neurotransmitters glutamate and to a 
small extend glycine (4). After light induced hyperpolarization of photoreceptor cells, the on-bipolar 
cells depolarize resulting in an excitation of the subsequent retinal ganglion cell. In contrast 
off-bipolar cells hyperpolarize after photoreceptor hyperpolarization leading to an inhibition of the 
consecutive retinal ganglion cell. 
Horizontal cells are situated at the outer aspect of the inner nuclear layer with large ramified 
dendrites in the outer plexiform layer (2). Depending on the species, there are up to 3 different 
subtypes of horizontal cells which release the inhibitory neurotransmitter GABA (12). Although the 
detailed mode of how horizontal cells mediate their effects is still under discussion (10,13), in the 
end horizontal cells sum up the light responses across a wide retinal region and subtract it from the 
local signal. This results in an improved contrast vision and allows seeing properly under dim as well 
as under bright light conditions (14).  
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1.1.1.4 Retinal glia cells: astrocytes, Müller glia cells and microglia 
The retinal astrocytes are found in the optic nerve fiber layer of the retina (15). Together with the 
Müller glia end feet they form the inner limiting membrane (16). Astrocytes play an important role 
during vasculogenesis for the proper guiding of the vessels towards the periphery of the retina. Later 
in development, they are part of the inner blood retinal barrier, which is composed of astrocytes, 
endothelial cells and pericytes (17). They also secrete the neuroprotective and angiogenic factor 
vascular endothelial growth factor (VEGF). This factor expressed from astrocytes turned out to be 
more important for the maintenance of vessel stability than the guiding of the vessels during 
vasculogenesis (18). 
Müller glia cells span the retina vertically (19). Their cell bodies are located in the inner nuclear layer 
(2), of which they comprise 16% of all the cells present in the INL (15). Müller glia end feet give rise to 
the outer and inner limiting membrane (16). The outer limiting membrane lies between the outer 
nuclear layer and the inner segments of the photoreceptors, whereas the inner limiting membrane 
lies on top of the nerve fiber layer. During angiogenesis, Müller glia cells build up a gradient of the 
angiogenic factor vascular endothelia growth factor (VEGF) that guides endothelial cells towards 
their designated localization. Additionally, Müller glia cells are of major importance for the 
maintenance of the retina in general. They express growth factors, neurotransmitter transporters 
and antioxidant agents to prevent retinal neurons from excitotoxic damage (16,19). The various 
Müller cell functions are shown as a schematic in Figure 2. The ability of Müller cells to secrete 
neuroprotective factors is of major importance for this project. 
 
Figure 2: Schematic of the different Müller cell functions 
Role of Müller glia cells in potassium (K
+
) and water homeostasis (I), neurotransmitter clearing (II), protection 
from oxygen free radicals (III) and the secretion of neuroprotective factors (IV). Picture taken from (20). 
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Microglia cells are the third glial population in the retina. Microglia cells represent the mononuclear 
phagocyte population of the nervous system (21). In the retina, they are located in the inner and 
outer plexiform layer and have important functions in immune surveillance and neuronal 
homeostasis (22–25). 
1.1.1.5 Cells of the outer nuclear layer (ONL): photoreceptors 
There are two types of photoreceptor cells: rod and cones. Rod photoreceptor cells are specialized 
for vision in dim light and provide black and white vision, whereas the cones operate during bright 
light, like daylight, and provide color vision (10).  
In the dark, the photoreceptor cells permanently release the neurotransmitter glutamate (4), which 
is thought to be the neurotransmitter of the vertical neurons in the retina (photoreceptor cells, 
bipolar cells and retinal ganglion cells). When light hits the rhodopsin molecule in the photoreceptor 
cell this results in a closure of ion channels (Na+ and Ca2+) which in turn results in a hyperpolarization 
of the photoreceptor cell and subsequently a diminished release of its neurotransmitter glutamate. 
(The detailed process of phototransduction is described in 1.1.2.1). 
Regarding the photoreceptor`s morphology one speaks of an inner and an outer segment, a cell 
body, which is situated in the outer nuclear layer (ONL) containing the nucleus of the photoreceptor 
cell, and the synaptic terminal, which is situated in the outer plexiform layer (OPL) where 
neurotransmission to downstream neurons occurs (2). The inner segment of the photoreceptors 
contains cell organelles like mitochondria, golgi apparatus, endoplasmatic reticulum and ribosomes 
(26). A cilium connects the inner with the outer segment of the photoreceptor. Figure 3 shows the 
ultrastructure of a rod and cone photoreceptor and a membranous disc stack. Photoreceptor cells 
have an outer segment composed of membranous discs (rod) or membrane enfolding (cones) that 
contain the photopigment (26). 
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Figure 3 Ultrastructure of photoreceptors 
A. Electron microscopy of rod and cones photoreceptors of a squirrel retina with the connecting cilium 
between the inner and the outer segments and an example of disc shedding in the retinal pigment epithelium. 
B. Electron microscopy of rod and cone photoreceptors of a monkey retina with enlargement of the outer 
segment discs. o.s.: outer segment, i.s.: inner segment. Slightly modified after (27). 
The opsin part is a membrane receptor that is assembled in the photoreceptor cell organelles of the 
inner segment and transported through the connecting cilium to their final destination in the 
membrane of the outer segment. In rod outer segments the final destination is in intracellular 
membrane disc stacks. These stacks are without contact to the plasma membrane (see Figure 3 and 
Figure 4). In cones, the disks are in contact with the plasma membrane (28,29), which is called 
'membrane enfolding' (30). 
 
Figure 4: Schematic of rod outer segment disc 
A. The rod outer segment is filled entirely with discs of folded double membranes. These membranes do not 
contact the plasma membrane of the photoreceptor cell. The light sensitive visual pigment is embedded in the 
intracellular disc membrane. Picture taken from (29).  
B. Schematic that illustrates the continuous distance between the plasma membrane and the intracellular 
situated membranous discs stacks. Picture taken from (28). 
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The complete renewal of a photoreceptor disc occurs about every 10 days. Newly formed discs are 
located at the base of the outer segment and within 10 days the discs displace progressively towards 
the retinal pigment epithelium. When they reach the RPE they are phagozytosed (26). This process is 
called shedding. To facilitate this process, the outer segments lay folded in the microvilli of the 
retinal pigment epithelium (1). The retinal pigment epithelium plays an essential role in removing 
and recycling the photoreceptor discs. 
To be precise, there is a third, but rare type of photoreceptor cell: the light sensitive ganglion cells 
that contain melanopsin as the photopigment. These cells are important for the circadian physiology, 
they are involved in the pupillary reaction to light by reflecting signals into brain regions like the 
olivary pretectal nucleus and they respond to blue spectral light (~ 480nm) independent of rod and 
cones (31).  
The arrangement of the photoreceptor cells lying at the very end of the light entering the retina 
seems to be counteractive. But apart from its formation during retinal development, there may also 
be functional reasons in the context of regeneration, as supported by the special relationship that 
exists between the outer segments of the photoreceptor and the retinal pigment epithelium.. 
1.1.1.6 The retinal pigment epithelium 
The retinal pigment epithelium has many different and very important functions for the maintenance 
of the eye (outlined in Figure 5). Among these are the secretion of growth factors (vascular 
endothelial growth factor (VEGF), pigment epithelium derived growth factor (PEDF), the epithelial 
transport to uphold the ion homeostasis for glia cells, the phagocytosis of sorted photoreceptor disks 
(shedding) and its ability of light absorption (32). 
 
Figure 5: The retinal pigment epithelium and its functions.  
Picture taken from (32). For details see main text. 
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One of its functions which is of major importance for the current project, lies in the biochemical 
machinery for the regeneration of the photopigment molecules, after they have been exposed to 
light. This process is called visual cycle. 
1.1.2 Phototransduction and visual cycle 
1.1.2.1 Phototransduction 
Vision starts with the conversion of light in an electric signal in the photoreceptor cells. This process 
is called phototransduction (Figure 6). After light (photon) absorption in the photopigment of the 
photoreceptor cell, a signaling cascade is initiated that changes the membrane potential of the 
receptor and leads in the end to a change of the amount of the neurotransmitter glutamate released 
by the photoreceptor synapses onto the cells in the inner nuclear layer (4).  
 
 
Figure 6: Phototransduction 
Photon absorption (hν) activates the rhodopsin molecule (R*) in the disk membrane. The activated rhodopsin 
initiates the exchange of the G-protein (transducin, G) bound GDP to a GTP. The activated α-subunit (G*) of the 
G-protein binds to phosphodiesterase (PDE) which results in its activation (PDE**) and hydrolysis of cGMP to 
GMP. This leads to closure of the cation ion channels (Na
+
, Ca
2+
) and the photoreceptor cell membrane 
hyperpolarizes. GDP= guanosine diphosphate; GTP= guanosine triphosphate; cGMP/cG= cyclic guanosine 
monophosphate; GMP= guanosine monophosphate. Figure taken from (34).  
The signaling cascade is mediated via G-proteins. The photopigment opsin itself is a membrane-
bound G-coupled receptor. The chromophore is 11-cis retinal, which is covalently bound to the opsin 
part. The opsin molecule is generated in the inner segment of the photoreceptor whereas the 
chromophore 11-cis retinal is delivered via interphotoreceptor matrix carrier molecules (retinal 
binding proteins, IRBP) from the retinal pigment epithelium (32). When a light photon hits the G-
coupled receptor, the 11-cis retinal changes its conformation into all-trans retinal – a phenomenon 
called photo isomerization. Subsequently the G- coupled receptor changes its conformation, 
resulting in its activation. Then the light activated photopigment activates the GTP-binding protein 
transducin. Transducin stimulates cyclic guanosine monophosphate (cGMP) phosphodiesterase 
(PDE). The PDE enzyme hydrolyzes cGMP to 5`GMP. Subsequently the cGMP gated ion (Na+ and Ca2+) 
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channels in the cell surface membrane close. This results in the hyperpolarization of the 
photoreceptor cell and modulation of the neurotransmitter release at the synaptic terminal (33). 
1.1.2.2 Visual cycle 
The visual cycle describes the regeneration process of all-trans retinal. As mentioned above (in 
1.1.2.1) when 11-cis retinal is photo isomerized, it changes its conformation into all-trans retinal. 
During the visual cycle, a “used” all trans-retinal is recovered back into the active 11-cis-retinal using 
several enzymatic recovery steps. This process takes place in the outer segments of the 
photoreceptors and the retinal pigment epithelium (see Figure 7). Between these structures and in 
the interphotoreceptor matrix, the retinal is transported using carrier proteins. 
 
Figure 7: Visual cycle 
Schematic showing the visual cycle with its light induced conformation change of 11-cis retinal into all-trans 
retinal and the following regeneration process in the interphotoreceptor matrix and retinal pigment 
epithelium, respectively. Figure taken from (28). 
The 11-all-trans retinal is released from the opsin protein, reduced to all-trans retinol and esterified 
by lecithin retinol acyltransferase (LRAT), converted to 11-cis retinol by the protein RPE65. Finally, 
11-cis retinol is oxidized to 11-cis retinal and moved back to the rod outer segment, where it is 
reconjugated to an opsin. A new functional visual pigment (opsin) is formed (28). 
In the context of light damage experiments (see 1.3.2) the proper function of the visual cycle is 
essential. Animal experiments with RPE65 knockout (RPE65-/-) mice and animals that did not express 
opsin in photoreceptors (Rho-/- mice) showed that these mice both are not sensitive to intense light 
exposure (35). RPE65-/- and Rho-/- animals did not develop any kind of light induced damage. These 
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results highlight the importance of rhodopsin in the context of light damage and its main impact on 
retinal degeneration, indicating that the G-coupled receptor is the receptor mediating the damaging 
effects of light (35). Additionally, the publication of Grimm and co-workers showed the importance of 
the RPE65 protein (visual cycle, see 1.1.2.2 and Figure 7) in the context of light induced 
photoreceptor damage. RPE65 deficiency protected against early signs of light mediated damage 
(vesiculation of photoreceptor rod outer segments), as well as against late effects (photoreceptor 
apoptosis). The authors pointed out the importance of “excessive” adsorption of photons by 
rhodopsin that induces a death cascade leading to apoptosis (35). 
Another observation highlights the importance of the visual cycle and the RPE65 gene in the context 
of light susceptibility. A point mutation at position 450 in the RPE65 gen has been shown to be of 
major important for the susceptibility of the animals to light damage. This mutation results in an 
amino acid exchange from methionine to leucine (36–38). Animals carrying the leucine variant of the 
Rpe65 protein are about 120-fold more sensitive to intense light than methionine carrying animals. In 
the current thesis, experimental animals were tested for the mutation and leucine carriers only were 
used for the experiments. 
1.1.3 Electrophysiology: Electroretinography (ERG) 
The electroretinography (ERG) method is used to in vivo evaluate the activity of the retinal neurons. 
In a standard ERG one distinguishes between a- and b-wave amplitude (see Figure 8). The negative a-
wave amplitude provides information about photoreceptor function and reflects their 
hyperpolarization upon activation, while the b-wave amplitude is indicative for the function of the 
neurons of the inner retina (post synaptic second and third order neurons). Using different light 
stimuli one can selectively activate either the rod or the cone pathway. In the current project, we 
used the ERG methods to analyze the neuronal function in the retina of our animals before and after 
light exposure. 
 
Figure 8: ERG response and parameters that are measured for diagnosis 
The a-wave indicates the activation of the photoreceptor cells, whereas the b-wave is the response of post-
synaptic second and third order neurons. The implicit time is the time between the light stimulus to the peak. 
Experiment performed by Barbara Braunger in cooperation with Prof. H. Jägle. 
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1.1.4 Retinal vessels in development and adulthood 
In the adult retina 3 different vascular layers can be distinguished. These layers are called plexus and 
named according to their localization in the retina: superior/superficial, intermediate and 
inferior/deep (39). The superior plexus lies on top of the retinal ganglion cell layer next to the 
vitreous; the intermediate vascular layer is situated in the inner plexiform layer next to the inner 
aspect of the inner nuclear layer. The inferior vascular plexus is localized in the outer plexiform layer 
next to the outer aspect of the inner nuclear layer (see Figure 9) (2,39).  
 
Figure 9: FITC- coupled Dextran perfusion showing intra-retinal vessel localization 
Retinal vessels of a 3 weeks old 129SV wild-type mouse. The vessels are perfused with high molecular FITC- 
Dextran (green) that stays in the vessel lumen due to its high molecular weight, which does not allow a passage 
through the blood retinal barrier. Cell nuclei are stained with DAPI (blue).The white arrows indicate the correct 
position of the superior, intermediate and inferior vascular plexus. GCL: ganglion cell layer, INL: inner nuclear 
layer, ONL: outer nuclear layer.  
In contrast to humans, retinal vessel development in the murine retina starts postnatally. This 
process in the mouse retina is thought to be restricted to angiogenesis (humans: vasculogenesis and 
angiogenesis) (40). During murine angiogenesis vessel sprouting starts at the optic nerve head (see 
Figure 10).The immature vessels sprout from the optic nerve head into the periphery following the 
guidance of astrocytes on the very top of the retina. At postnatal day (P) 8 the vessels reach the 
periphery (Figure 10). Then, in the further process of angiogenesis, the vessels start to grow into the 
retina as early as P9. They form the deep vascular plexus in the outer plexiform layer. The 
intermediate vascular plexus begins to develop starting at P12 (39). In contrast, in the human retina, 
the plexus are formed in the following order: superior, intermediate and inferior plexus). 
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Figure 10: Retinal vessel development – superior vascular plexus 
Superior vascular plexus development of C57Bl6 mice retinae. The endothelial cells are labeled using isolectin 
B4-Alexa 496 (red). At postnatal day 1 (P1N), the vessels are only present at the optic nerve head. From there, 
they extend radial, reaching the periphery at P8N. Figure taken from (39). 
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1.2 Norrin 
1.2.1 Norrie disease: symptoms and genetics 
The Norrie syndrome is a congenital X linked recessive disease. The major symptoms of this disease 
are ophthalmological findings such as atrophic irides, corneal clouding, cataract and retinal dysplasia 
with early vascular proliferation (pseudoglioma) followed by bulbar atrophy. Additionally, the 
affected patients show progressive sensorineural hearing loss, psychotic features and one third of 
the patients demonstrate mental retardation (41–47). The localization of the Norrie disease gene on 
the proximal short arm of the X chromosome (Xpll.3) was assigned using deletion and linkage analysis 
(48–52). The gene is located 60 kilobases (kb) proximal of the monoamine oxidase B (MAOB) gene 
and its 5`end is oriented towards the centromere. The Norrie gene is evolutionary-conserved (53). 
Interestingly, two other ophthalmologic diseases are either genetically linked to the same region 
(familial exudative vitreoretinopathy, FEVR) (54–59) or linked to the receptor which binds Norrin, the 
frizzled 4 receptor (autosomal-dominant familial exudative vitreoretinopathy) (60). The X-linked form 
of familial exudative vitreoretinopathy (FEVR) is caused by missense mutations in Norrin (54–59), 
while the autosomal-dominant familial exudative vitreoretinopathy is caused by mutant frizzled-4 
and is characterized by incomplete vascularisation of the peripheral retina (61). 
1.2.2 The protein Norrin 
The Norrin gene contains three exons that are transcribed into an mRNA of 2.1 kb (52). The murine 
Norrin gene encodes for a secreted protein of 131 amino acids with a molecular weight of about 17 
kDa (62). Based on multiple sequence alignments of Norrin with TGF and the resulting similarities 
one assumes Norrin has a cysteine rich domain. In silico analyses of its tertiary protein structure 
predict a cysteine knot motif (63,64).  
Norrin, or Norrin disease pseudoglioma (Ndp), is expressed in retinal neurons (outer nuclear layer 
(ONL), inner nuclear layer (INL), ganglion cell layer (GCL), Müller glia cells, the choroid, the fetal brain 
(cerebellar granular layer, hippocampus, olfactory bulb and cortex), the stria vascularis of the 
cochlea, decidua, uterus and human placenta. It is expressed in fetal, as well as in adult stages. 
(51,52,67–71). Recent data coming from a Norrin knock-in mouse that carries the coding sequence of 
human placental alkaline phosphatase (AP) as a reporter gene inserted at the Ndp locus (Ndp(AP)) 
further elucidated the expression pattern of Norrin during mouse embryonic development (72). 
These mice showed distinct AP-staining, which indicated Norrin expression, in the central nervous 
system (CNS) starting from E10.5. Postnatally, the expression in the CNS is restricted to astrocytes in 
the forebrain and midbrain, the Bergmann glia in the cerebellum and in the retina, the Müller glia 
cells. In the cochlea, the Ndp(AP) expression is associated with two compactly vascularized regions 
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the first is the stria vascularis and the second a capillary plexus between the Corti organ and the 
spiral ganglion (72). 
 
Figure 11: Structure of the Norrin gene and protein 
(A) The genomic structure of the Norrin gene. (B) The protein sequence of Norrin. The 3 braces indicate 
putative evolutionarily conserved disulfide bonds. They are expected to form the cysteine knot motif. (C) 
Predicted 3D structure of the human Norrin protein. The yellow stick models show the cysteine residues of the 
cysteine-rich domain. This domain is predicted to adopt a cysteine knot motif. Figure taken from (65,66).  
 
1.2.3 The biological functions of Norrin 
1.2.3.1 Angiogenic properties of Norrin 
Norrin deficient (Ndpy/-) mice show a prominent retinal phenotype. It is mainly characterized by the 
complete absence of the intermediate and inferior vascular plexus and the formation of vascular 
membranes at the vitreal surface of the retina (73). The number of blood vessels in the interface of 
the ganglion cell layer and the nerve fiber layer was significantly increased in Ndpy/- mice. In contrast, 
a drastic decrease was observed in the vessel number of the inner and outer plexiform layers in 9 day 
old Ndpy/- mice (74). Vessels were adjacent to the inner limiting membrane, which they penetrated 
occasionally and the hyaloid vessels were still present. Electron microscopy revealed fenestrations of 
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the vessels (74). Taken together, these observations in Ndpy/- mice demonstrated angiogenic 
malformations in the absence of Norrin, comparable to those observed in humans with Norrie 
disease (75). This indicates that Norrin is essential for vascular development of the inner retinal 
layers, especially for the development of inferior vascular plexus, and for the atrophy of hyaloid 
vessels (74,76). Vascular changes are also described for the auditory system, where the stria 
vascularis of Ndpy/- mice is the most affected structure (69). Taken together, this implies the 
important role for Norrin in basic vascular biology.  
To further investigate the angiogenic properties of Norrin, Ndpy/- mice were crossed with transgenic 
Norrin animals (Nor-29). Nor-29 mice overexpress Norrin lens-specifically under the control of the 
B1-crystallin promoter (73). The ectopic Norrin expression in the lens restored retinal structure and 
function in Ndpy/- mice. Additionally, double transgenic animals (Nor-29/Ndpy/-) also developed both 
retinal capillary beds. The capillaries were covered by pericytes and surrounded by a complete basal 
lamina and they showed typical ultrastructural characteristics of retinal capillaries. In summary, the 
ectopic transgenic expression of lens-derived Norrin completely restored normal vascular 
development of the retina, compared to Ndpy/- mice (73).  
1.2.3.2 Neuroprotective properties of Norrin 
Ndpy/- mice showed disorganized retinal ganglion cells which migrate into the inner plexiform layer. 
Quantification of the number of retinal ganglion cells in Ndpy/- mice compared to wild-type 
demonstrated a decreased number of retinal ganglion cells in knockout animals (74). In contrast, the 
cell number (retinal ganglion cells and during retinal development: neurons in the marginal and 
ventricular zone) in the transgenic Norrin overexpressing Nor-29 animals was significantly increased. 
Furthermore, double transgenic animals (Nor-29/Ndpy/-) showed a rescue of retinal ganglion cells loss 
in cell number (73).  
Ndpy/- mice showed sporadic variations the inner and outer nuclear layer cell morphology. Those 
regions that were severely affected exhibited a degeneration of the outer plexiform layer and the 
outer segments of the photoreceptors. Furthermore, in these regions the retinal pigment epithelium 
(RPE) was hyperpigmented (77). Loss of the anti-apoptotic functions of Bcl-2 interacting death 
suppressor (Bis) and Fas apoptosis inhibitory molecule (Faim) in Ndpy/- mice may contribute to the 
degeneration of photoreceptor cells during disease progression (78).  
Taken together, these findings support the idea of a neuroprotective activity of Norrin. Cell culture 
experiments with RCG-5 cells, treated with only staurosporine (SS) resulted in cell death, whereas 
RCG-5 cells treated with SS and Norrin showed less apoptosis (79). In another approach, the possible 
neuroprotective role of Norrin was investigated using an animal model, in which an exitotoxic (using 
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N-methyl-D-aspartic acid (NMDA)) retinal ganglion cell death was induced. To this end, intravitreal 
Norrin injections in N-methyl-D-aspartic acid (NMDA) treated animals provided the evidence for a 
protective role of Norrin for retinal ganglion cells (RGC) survival (80). The double treated animals 
(NMDA+Norrin) demonstrated a minor loss of axons in the optic nerve and the area of glial scarring 
appeared to be considerable smaller, compared to eyes treated with NMDA alone. TUNEL labeling 
confirmed the significant inhibition of the RGC apoptosis after NMDA+Norrin injections (80). Norrin 
injections into NMDA damaged eyes resulted in Müller glia cell activation and enhanced Endothelin-2 
(EDN2)/leukemia inhibitory factor (LIF) signaling. Experiments with an inhibition of the 
Wnt/β-catenin pathway using Dickkopf-1 indicated that the neuroprotective effect of Norrin is most 
probably mediated by the Wnt/-catenin pathway (80). In summary, this study showed that Norrin is 
part of an endogenous protective system in the retina which is important for RGC survival during and 
after injury (80). The endogenous protective system appears to act largely independent from the 
effects of Norrin on vascular development and repair (71,80).  
1.2.3.3 Norrin in reproduction and development 
The expression of Norrin in murine deciduae was confirmed using RNA in situ hybridization (70). 
Transcripts of the NDP gene could be detected in decidua and uteri of wild-type mice and in human 
placentae, indicating an additional role for Norrin in reproduction (70). The distinct reduction of 
decidualization in female Ndp-/- mice resulted in an impaired female fertility. Compared to wild-type 
mice, the deciduae were also smaller in female Ndp-/- mice and did not reach as deep into the 
endometrium (70). In addition, fibrocytes of the deeper endometrial zone did not show transition to 
large roundish decidua cells and they were separated from each other by wide intercellular spaces 
(70). In summary, Norrin affects reproduction in two possible ways: on the one hand it impairs the 
correct vascularization of the deciduae resulting indirectly in a decreased female fertility. On the 
other hand, Norrin deficiency resulted in the malformation of endometrial fibrocytes, which 
implicates a more direct role of Norrin in decidualization. 
During retinal development, Norrin stimulates the proliferation of neurons. This has been shown in 
Norrin overexpressing animals (Nor-29 mice) that exhibited a significant higher number of 
bromo-desoxyuridine (BrdU) positive cells in the retina at E14.5. During DNA synthesis, BrdU 
incorporates in the DNA of the replicating cell and is therefore used for the detection of cell 
proliferation in living tissue. The increased number of BRDU positive cells in Nor-29 mice indicated a 
growth stimulatory effect of Norrin on retinal neurons. The increased proliferation led to a thicker 
retina and an increased cell number of retinal ganglion cells and other neurons at P2. However, 
Norrin most probably does not influence the rate of apoptosis directly, since no significant difference 
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was found in the number of apoptotic cells (TUNEL, see 5.1.5.4) at P7 between Nor-29 and wild-type 
littermates (73). 
1.2.4 Norrin signaling and the Wnt/β-catenin pathway 
In the absence of a Wnt (Wingless-related integration site) ligand (inactive Wnt pathway, see Figure 
12, left hand side), β-catenin forms a complex composed of APC (Adenomatous polyposis coli), GSK-
3β (Glycogen synthase kinase-3β), CK1 (Casein kinase 1, alpha 1) and Axin in the cytosol (81,82). In 
this situation β-catenin is phosphorylated, ubiquitinylated through the E3-ubiquitin-ligase β-Trcp (β-
transducin repeat containing) and degradated by the proteasome (81). In summary, an inactive Wnt 
pathway results in a constant degradation of the intracellular β-catenin levels.  
 
Figure 12: Schematic of the canonical Wnt pathway. 
Left: in the absence of Wnt ligand, a complex of Axin, APC, GSK3-β, CK1 and β-catenin is located in the cytosol. 
β-catenin is phosphorylated by CK1 and GSK3-β and degraded by the proteosomal machinery mediated by 
β-Trcp.  
Right: Wnt signaling through the Fz receptor and LRP5/6 co-receptor complex induces the phosphorylation of 
LRP6 and this leads to a translocation of the protein complex containing Axin from the cytosol to the plasma 
membrane. Dsh is also recruited to the membrane and binds to Fz. This results in a stabilization of β-catenin, 
which subsequently translocates into the nucleus. There it complexes with Lef/Tcf family members to mediate 
the transcription of target genes. APC= Adenomatous polyposis coli). GSK-3β= Glycogen synthase kinase-3β. 
CK1= Casein kinase 1, alpha 1. β-Trcp= β-transducin repeat containing. Dsh= dishelved. Figure taken from (83). 
Wnt pathway activation (see Figure 12, right hand side) leads to a phosphorylation of Lrp5/6, which 
in turn results in a translocation of the some proteins from the β-catenin complex from the cytosol to 
the plasma membrane. Axin binds to phosphorylated Lrp5/6 and Dsh is recruited to binds to the Fz 
receptor (81). This complex formed of Fz/Lrp5/6 induces the stabilization of β-catenin in the cytosol 
either through sequestration and/or degradation of Axin. β-catenin translocates into the nucleous 
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where it forms a complex with Lef/Tcf family members resulting in the transcription of Wnt- signaling 
target genes (81,82).  
Despite the canonical Wnt/β-catenin pathway, which results in a β-catenin accumulation in the cell, 
there are two other possible Wnt-pathway activations that do not result in an intracellular β-catenin 
accumulation: the non-canonical planar cell polarity pathway and the non-canonical Wnt/Ca2+ 
pathway (83).  
Norrin shows specific and strong affinity binding to the frizzled 4 receptor (Fz4) (84). In consequence 
Norrin and fz4 mutations in both, human and mice (see 1.2.3.1 and 1.2.3.2) result in very similar 
morphological phenotypes (60,84,85). After Norrin binds to the Fz4 receptor, the canonical Wnt/-
catenin pathway is activated as shown in Figure 13, B (84). 
Dickkopf-1 (DKK1) binds with high affinity to Lrp5 and 6 and is used in the current thesis to inhibit the 
Norrin mediated Wnt/β-catenin pathway activation (86,87). 
A recent study showed that the transmembrane protein Tspan12 (Tetraspanin 12) is able to enhance 
specific the activity of Norrin/β-catenin signaling and not Wnt/ β-catenin signaling (88). Tspan 12 is 
expressed in the retinal vasculature, but not in other neuronal cell types. The authors discuss a 
Tspan 12 mediated enhanced clustering of Fz4 receptor complexes (receptor multimerization) thus 
also enhancing Norrin/β-catenin activity. Consistently, the phenotype of Tspan 12 knockout mice is 
comparable to those of the Ndpy/- (see 1.2.3.1), Fz4-/- and Lrp5-/- knockout (88). 
Norrin is in addition able to bind to the Lgr4 receptor (Leucine-rich repeat containing 
G protein-coupled receptor 4) and stimulates the canonical Wnt signaling though Lgr4 binding and its 
activation (89). However, binding studies using AP (alkaline phosphatase) coupled Norrin showed a 
higher Norrin binding affinity to Fz4 than to Lgr4 (89). In a study using xenopus as a model, Norrin 
interacted with the TGFβ (transforming growth factor β) signaling ligands BMP4 (bone morphogenic 
protein 4) and Nodal1 resulting in an inhibition of the TGFβ signaling pathway (90). Similar results 
were obtained in mammal cell culture assays, where Norrin acted as an antagonist of BMP2 and 4, 
resulting in a BMP signaling pathway inhibition (affecting intracellular Smad1/5/8) (89). Taken 
together, Norrin is considered as a multifunctional ligand to three receptor/binding proteins that are 
of major importance for Wnt and BMP signaling pathways.  
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Figure 13: Schematic of Norrin binding to frizzled 4/LRP5/6 receptors  
A. Inactive: β-catenin is part of a complex composed of APC (Adenomatous polyposis coli), GSK-3β (Glycogen 
synthase kinase-3β), CK1 (Casein kinase 1, alpha 1) and Axin in the cytosol. β-catenin is phosphorylated, 
ubiquitinylated processed to proteasomal degradation. 
B. Active: Wnt pathway activation leads to a phosphorylation of Lrp5/6, which allows a translocation of Axin to 
the phosphorylated Lrp5/6. Dsh is recruited to bind to the Fz receptor. β-catenin is stabilized in the cytosol and 
translocates in the nucleous. There β-catenin and Lef/Tcf family members induce the transcription of Wnt- 
signaling target genes.  
APC= Adenomatous polyposis coli). GSK-3β= Glycogen synthase kinase-3β. CK1= Casein kinase 1, alpha 1. β-
Trcp= β-transducin repeat containing. Dsh= dishelved. Figure taken from (66) 
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1.3 Animal models to induce cell specific stress 
1.3.1 The retinopathia of prematurity (ROP) model 
The disease retinopathia of prematurity (ROP) in humans is characterized through 2 phases: a time 
period of vaso-obliteration followed by retinal neovascularization (91,92). The ROP animal model 
reflects the pathogenesis of the human disease. This animal model is used to investigate vascular 
conditions in which vascular development becomes unbalanced (93). In the ROP model, mice are 
exposed to high levels of oxygen (75%) for a designated duration (detailed methodical explanation: 
see 5.1.6.1). The high levels of oxygen induce a vaso-obliteration and growth arrest of the developing 
retinal vessels (93). Relocalization of the experimental animals back to normal room air leads to a 
relative hypoxia in the tissue (due to the former growth arrest) and this results in uncontrolled vessel 
growths (neovascularizations: due to the expression of vascular endothelial growth factor (VEGF) and 
insulin growth factor (IGF)) (91,93). In the current thesis, we used this model to investigate the 
influence of Norrin on vessel growth and retinal vascularization. 
1.3.2 A damage model for photoreceptor degeneration: light damage 
Exposure of rat or mouse eyes to bright, visible light leads to death of their rod photoreceptors (94). 
This vulnerability to light has been used to establish the experimental model of light-induced 
damage. Photoreceptors exposed to excessive amounts of light die through apoptosis, a scenario 
that is quite similar to their apoptotic death seen in inherited retinal dystrophies or in age-related 
macular degeneration (AMD) (95,96). Animal models for inherited retinal dystrophies or AMD are 
available and commonly show photoreceptor apoptosis over a relative long period of time, with only 
a few neurons entering apoptotic cell death each day. In contrast, photoreceptor death induced by 
excessive light leads to a large number of photoreceptors dying at the same time. Accordingly, 
studies on the molecular mechanisms of photoreceptor apoptosis and/or on neuroprotective 
signaling pathways preventing apoptotic death are considerably easier. Light damage can be induced 
in an acute or chronic way, by exposing animals to light for a short or longer period of time. In 
addition, different qualities of light can be used, such as fluorescent white light with an emission 
spectrum similar to that of daylight, or energy-rich blue light (94,97,98). In the current thesis, light 
exposure was used to investigate whether Norrin has neuroprotective effects on photoreceptor cells 
and which molecular mechanism may mediate this effect. 
1.3.3 Neuroprotective signaling pathways in the context of photoreceptor degeneration 
In the context of light damage and neuroprotection several neuroprotective factors are discussed. 
Microarray analysis revealed a relatively small number of genes activated after light exposure (99). 
Among those transcripts endothelin 2 (Edn2) was highly upregulated (99). Its localization in the ONL 
was determined using in situ hybridization (99). In addition, the endothelin receptor type B (Ednrb) 
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was upregulated in Müller glia cells indicating that photoreceptor derived Edn2 signals to Müller glia 
cells to probably increase their sensitivity to Edn2 as part of the retinal tissue response to the light 
damage (99).  
It was also shown that photoreceptor cell death in VPP mice (a model for inhereditary photoreceptor 
degeneration) strongly induced the expression of leukemia inhibitory factor (LIF) in Muller glia cells 
(100). Lif-/- animals revealed accelerated photoreceptor degeneration in the VPP mouse model 
without activating the Müller glia cells (100). Similar to the situation in light damaged retinae, Edn2 
was significantly upregulated in VPP retinae as well (99,100). Intravitreal injections of recombinant 
LIF in turn induced molecular factors like Edn2, signal transducer and activator of transcription 
(Stat3), fibroblast growth factor 2 (Fgf2) and glial fibrillary acidic protein (Gfap) in wild-type, VPP and 
interesstingly in Lif–/- mice, too. These findings strongly indicate that the upregulation of those factors 
are mediated through LIF. The fact that Edn2 levels in Lif-/- animals were reduced to the level of 2% 
compared to wild-types and that VPP;Lif-/- double mutants did not reveal an upregulation of Edn2 
(although VPP animals did) further indicates that Edn2 expression is dependent on LIF.  
 
Figure 14: The response of photoreceptors to injury: EDN2, LIF and FGF2 
Light or genetically induced photoreceptor cell stress results in the upregulation of LIF. Strikingly, Lif induction 
leads to an upregulation of EDN2 in photoreceptor cells and FGF2 in Müller glia cell. Since EDN2 itself further 
stimulates the expression of LIF, a positive feed forward loop is very likely. 
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FGF2 is upregulated in different models of photoreceptor degeneration and it is speculated that 
endogenous FGF2 may function in a parakrine way, secreted from the Müller glia cells, as a 
protective factor activated in response to photoreceptor cell stress (101,102). When Fgf2 and Müller 
glia cell activation marker Gfap were studied in Lif-/- and VPP;Lif-/- mice respectively, again, the Fgf2 
and Gfap levels in Lif-/- animals were reduced to a level of 38% (Fgf2) and 11% (Gfap), respectively. 
VPP;Lif-/- double mutants did not reveal an upregulation of Fgf2 or Gfap (although VPP animals did) 
(100). This further indicates that the expression of FGF2 and GFAP is dependent on LIF as well.  
Taken together LIF/EDN2/FGF2 signaling pathways (see Figure 14) seem to play an essential and early 
role in the retinal response to photoreceptor injury. 
 
  
Introduction 
22 
 
1.4 Aim of the current work 
The main focus of this thesis is to investigate the neuroprotective role of Norrin on photoreceptor 
survival and maintenance. To this end, we will use a transgenic mouse line that overexpresses Norrin 
specifically in the retinal pigment epithelium (RPE).  
First, we will carefully characterize the overexpression of Norrin in the transgenic animals using 
various molecular biology techniques. Then we will analyze the effect of Norrin on photoreceptor 
survival in untreated animals. To this end, we will characterize the morphology of the animals at 
different timepoints, followed by morphometric analysis. For morphometry, we will measure the 
thickness of the photoreceptor cell layer (outer nuclear layer, ONL) at 20 measure points throughout 
the entire retina and blot these measure points in a so called spider diagram. We will evaluate the 
different measure points in the spider diagram using Student's t-test. This will give us a good 
indication, if Norrin has proliferative effects on the outer nuclear layer (ONL). Since Norrin has strong 
angiogenic properties, the retinal vasculature will be examined by dextran perfusion, in vivo 
fluorescence angiography and immunohistochemical staining (Isolectin B4, plasmalema associated 
protein (PLVAP)).  
To investigate a possible neuroprotective function of Norrin for photoreceptors, we will 
consequently establish a light induced damage model for photoreceptor apoptosis. Using the 
established model, we will treat transgenic animals and littermate controls. TUNEL labeling for 
apoptotic cells will show, if the transgenic overexpression of Norrin might have a protective effect on 
photoreceptor survival (less apoptosis). These results will be confirmed with an ELISA, which detects 
free nucleosomes as a sign for apoptosis. Additionally, we will focus on the morphology and use 
Spider diagrams and Student's t-test to compare the thickness of the ONL of light exposed animals. 
To learn more about the underlying molecular mechanisms, transcript levels of different 
neuroprotective factors (leukaemia inhibitory factor (Lif), fibroblast growth factor 2 (Fgf-2), 
endothelin-2 (Edn-2), brain derived neurotrophic factor (Bdnf), lens epithelium derived growth factor 
(Ledgf), ciliary neurotrophic factor (Cntf), pigment epithelium derived growth factor (Pedf)) and as a 
marker for Müller glia cell activation: glial fibrillary acidic protein (GFAP) will be determined before 
and after light exposure. Western blot analysis and immunohistochemical staining will be performed 
to confirm realtime-PCR data on the protein level. In vivo examinations like, e.g. ERG-, OCT- and SLO- 
analysis will be performed in cooperation with Prof. Seeliger (Tübingen) to complete the dataset with 
a functional aspect.  
Finally we will investigate in detail the possible mechanism by which Norrin mediates its 
neuroprotective effects. Norrin can activate the canonical Wnt/β-catenin pathway (103). Hence, 
Western blot analysis for β-catenin will be performed. In addition, crossbreeding of transgenic Norrin 
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animals with TopGal mice (Wnt signaling reporter mice, see 5.1.1.3) will reveal if the Wnt pathway is 
more active in the transgenic animals. Wnt signaling is neuroprotective (80,104,105). Consequently, 
if transgenic animals show neuroprotective effects following light damage, we will investigate, if this 
effect might be mediated through the classical Wnt/β-catenin pathway. To this end, we will inhibit 
Wnt signaling using vitreal Dkk-1 injections. We will inject Dkk-1 into the vitreous of the left eye; the 
right eye will be injected with PBS only, followed by light damage experiments. Spider diagrams of 
PBS and Dkk-1 injected transgenic and wild-type control animals will be constructed and statistical 
analysis will be performed. The expression levels of possible target genes of Norrin and 
Wnt/β-catenin signaling will be investigated after injection of Dkk-1 in untreated and light exposed 
animals. Possible downstream signaling pathways of the target genes will be analyzed using Western 
Blot analysis and immunohistochemical staining. 
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2 Results 
2.1 Characterization of Rpe65-Norrin-2 mice 
2.1.1 Southern Blot: successful genomic insertion of the transgene construct 
To analyze if the transgene construct was successfully integrated into the genome of Rpe65-Norrin 
mice, southern blot analysis was used. To this end, genomic DNA was cut with the restriction enzyme 
EcoRV, transferred on a agarose gel on which the DNA fragment were separated by their size. 
Subsequently, the DNA was blotted onto a positively charged nitrocellulose membrane. After 
membrane hybridization with the digoxygenin (DIG) labeled RNA-probe, a RNA-DNA hybrid was 
formed, which was detected using the DIG easy system with alkaline phosphatase as 
chemiluminescence.  
 
Figure 15: Southern blot analysis of the different Rpe65-Norrin founder mouse lines 
Southern blot analysis showed a distinct signal for wild-type Norrin DNA. Line 25 showed a second band 
positive for the Norrin probe indicating a successful insertion of the transgene construct into the genomic DNA.  
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Rpe65-Norrin-line 2 animals showed a distinct second signal in addition to the wild-type Norrin 
signal, which was detectable in control animals (wild-type) and Rpe65-Norrin-line 1 animals (second 
transgene mouseline) (Figure 15). Mentioning the fact that the lanes are obviously not equally 
loaded, one might have the impression of a very weak additional second signal above the wild-type 
signal in the Rpe65-Norrin-line 1 tail DNA (Figure 15, lane 4). 
2.1.2 Northern blot analysis: effective transcription of the construct 
Northern blot analysis was used to further verify if the successfully integrated Norrin transgene 
construct is being transcribed in the eye. To this end carefully isolated RNA samples from the 
posterior bulb (sample containing the retina, RPE, choroid and sclera) were pretreated as described 
in 5.1.3.5, loaded on an agarose gel and separated by size. The RNA in the gel was transferred on a 
positively charged nitrocellulose membrane, hybridized with the same probe as used for Southern 
blot analysis and the RNA-RNA Hybrid was detected using DIG easy system with alkaline phosphatase 
as chemiluminescent reagent. Rpe65-Norrin-2 animals showed a signal on the same height as the 
positive control (βB1-Norrin). The signal in Rpe65-Norrin-2 retinae appeared weaker compared to 
controls, a phenomenon which is not surprising at all, because it is well known, that the promoter 
(βB1-crystallin) in these positive controls is far more effective than the RPE65 promoter used in our 
mouse line in this project (Figure 16).  
 
Figure 16: Northern Blot analysis of Rpe65-Norrin-2  
 Rpe65-Norrin-2 animals show a distinct signal at the appropriate size. On the right: coomassie blue staining of 
the membrane to show equally loaded lanes, especially for the wild-type, since there was no signal visibly in 
the northern blot. 28 S and 18 S indicate the large and small ribosomal RNAs. Experiment published in (106), 
performed by Barbara Braunger. 
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2.1.3 Western blot analysis: effective protein translation 
To further confirm, whether the RNA was successfully translated into Norrin protein, which in the 
end would stand for a successful overexpression of Norrin protein in the retina, Western blot analysis 
was performed. After statistical evaluation of the Western blot densitometry, Rpe65-Norrin-2 
animals had indeed a significant, about 2-fold increase of Norrin protein in the retina (Figure 17).  
 
Figure 17: Western blot for Norrin in Rpe65-Norrin-2 mice 
Left: Western blot analysis for Norrin protein in retinal lysates of Rpe65-Norrin-2 mice compared to wild-type 
littermates.  
Right: statistical evaluation (students t-test) of the densitometric analysis.  
 Rpe65-Norrin-2 animals showed a significant increase of Norrin in the retina compared to their wild-type 
littermates. Mean and SEM are shown; n= 8; *p<0.05. Experiment published in (107), performed by Barbara 
Braunger. 
 
2.1.4 Immunohistochemistry: retinal localization of the transgenic Norrin protein 
To investigate in which region or cellular layer of the retina the significant overexpressed Norrin was 
localized, immunohistochemical staining was performed (Figure 18). In adult control animals, specific 
immunostaining for Norrin was weak and barely detectable in the outer retina. In contrast 
Rpe65-Norrin-2 animals showed an intense staining for Norrin in the inner and outer segments of the 
photoreceptors, the ONL and the outer plexiform layer. This strongly indicated that Norrin was 
secreted from the retinal pigment epithelium into the retina. 
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Figure 18: Immunohistochemical staining for Norrin in the retina 
 Rpe65-Norrin-2 showed an intense staining for Norrin (green) in the outer and inner segments of the 
photoreceptors, the ONL and the outer plexiform layer (arrows). Cell nuclei were stained with DAPI (blue). INL= 
inner nuclear layer; ONL= outer nuclear layer. Experiment published in (107), performed by Barbara Braunger.  
 
2.1.5  Rpe65-Norrin-2 mice and Wnt/β-catenin activation 
Norrin activates the canonical Wnt/β-catenin pathway by binding to the Frizzled-4 receptor (see 
Figure 13) (60,85,103). To investigate whether the Wnt/β-catenin pathway was activated in the 
transgenic Rpe65-Norrin-2 animals, western blot analysis of β-catenin levels was performed. 
Densitometric and statistic evaluation showed that Rpe65-Norrin-2 animals had a significant increase 
in β-catenin protein in the retina compared to control wild-type littermates (Figure 19). 
 
Figure 19: Western blot analysis for β-catenin in Rpe65-Norrin-2 animals 
 Rpe65-Norrin-2 animals had a significant increase for β-catenin protein in the retina. Mean and SEM are 
shown; n≥7; *p>0.05. Experiment published in (107), performed by Barbara Braunger. 
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To investigate if the increase in retinal β-catenin in the retina correlated with an activation of the 
canonical Wnt/β-catenin signaling pathway, Wnt reporter mice (TOPGAL) were crossed to the 
Rpe65-Norrin-2 line and β-galaktosidase staining was performed. 
 
Figure 20: Wnt pathway reporter mice (TOPGAL): macroscopic picture of β-galactosidase stained eye. 
Macroscopic pictures of the eyes of Lac-Z stained TOP-Gal;wild-type and TOP-Gal; Rpe65-Norrin-2 animals. The 
sample of Rpe65-Norrin-2 mice showed a strong β-galactosidase reactivity compared to wild-types.  
 
In control animals only a weak positive signal was detected in the innermost layers of the retina, in 
contrast double transgenic Rpe65-Norrin-2 X TOP-Gal animals showed an intense β-galaktosidase 
signal (Figure 20) throughout the retina (Figure 21), which indicates an active Wnt/β-catenin 
pathway. Taken together, these experiments strongly pointed out that the canonical Wnt/β-catenin 
pathway was activated in the retina of transgene Rpe65-Norrin-2 animals. 
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Figure 21: Wnt pathway reporter mice (TOPGAL): β-galactosidase staining 
Rpe65-Norrin animals showed an intense β-galactosidase staining, which indicates an active Wnt/β-catenin 
pathway. INL= inner nuclear layer; ONL= outer nuclear layer. Experiment published in (107), performed by 
Barbara Braunger.  
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2.2 Phenotype analysis of Rpe65-Norrin-2 animals 
2.2.1 Retinal morphology 
Conventional light microscopy was used to analyze the morphology of Rpe65-Norrin-2 animals and 
wild-type littermates at different time points by using Richardson stained semithin sections. Although 
we observed a strong overexpression of Norrin from the retinal pigment epithelium into the retina, 
the phenotype of the transgenic animals showed no morphological differences. The sizes of wild-type 
and transgenic eyes were similar, the anterior segment of the eye was regular formed, and the 
retinae showed a normal architecture with all layers present from the optic nerve to the periphery. 
The retinal pigment epithelium (RPE) looked normal with no visible alterations (Figure 22).  
 
Figure 22: Semithin sections of adult Rpe65-Norrin-2 and control wild-type littermates eyes 
Semithin (1 μm thick) horizontal sections of eyes of a 6 week-old Rpe65-Norrin-2 mouse and its wild-type 
littermate. The eyes were of similar sizes and the architecture of the retina was normal with all layers present 
from the optic nerve to the periphery. Lower panel shows higher magnification of the central retina 
Rpe65-Norrin-2 animals. There was no obvious morphological change compared to control wild-type 
littermates. Experiment published in (107), performed by Barbara Braunger. 
Because the thickness of the outer nuclear layer is the major read out data point for morphometric 
analysis of light damage experiments, prior to the actual light damage experiments the thickness of 
the outer nuclear layer throughout the entire retina was measured. The ONL thickness did not differ 
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between transgenic mice and wild-type littermates (Figure 23). Consequently, the ONL thickness 
could be used it as read out following light exposure without any further normalization. 
 
Figure 23: Spider diagram of untreated animals  
The thickness of the outer nuclear layer (ONL) was measured on horizontal semithin sections of eyes of 
untreated Rpe65-Norrin-2 animals and wild-type littermates. To this end, the distance between the ora serrata 
(OS) and the optic nerve head (ONH) was divided into tenths and the thickness of the ONL was measured at 
each tenth. Data is mean ± SEM, n=5 per group. Experiment published in (107), performed by Barbara 
Braunger. 
 
2.2.2 Ultrastructure of Rpe65-Norrin-2 animals 
Since the overexpression of Norrin protein in Rpe65-Norrin-2 animals was driven by a RPE specific 
promoter, transmission electron microscopy was performed of the very region to confirm the normal 
structure and morphology of the RPE. More specifically, transmission electron microscopy did not 
detect differences in the ultrastructure of RPE and adjacent photoreceptor outer segments (Figure 
24). 
 
Figure 24: Ultrastructure of the RPE in Rpe65-Norrin-2 animals 
Transmission electron microscopy of the retinal pigment epithelium and photoreceptor outer segments. No 
morphological ultrastructural difference was detected. Experiment published in (107), performed by Barbara 
Braunger. 
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2.2.3 Vascular phenotype 
We subsequently analyzed the retinal vasculature of Rpe65-Norrin-2 mice, because Norrin is 
important for retinal angiogenesis during development. Transgenic overexpression of Norrin in the 
lens leads to a persistence of the tunica vasculosa lentis and the hyaloid vasculature (73). In vivo 
funduscopy and angiography was performed and a normal configuration of the retinal vasculature 
was observed in wild-type controls and transgenic Rpe65-Norrin-2 littermates (Figure 25).  
 
Figure 25: In vivo funduscopy and angiography in Rpe65-Norrin-2 animals 
 Rpe65-Norrin-2 animal showed a comparable vascular phenotype than the wild-type control littermates. In 
vivo funduscopy (top row) and fluorescein angiography (middle row) did not show obvious differences between 
the eye of a 2-month-old Rpe65-Norrin-2 mouse and its wild-type littermate. FITC–dextran perfused retinal 
whole mounts (lower row) of a 6-week-old Rpe65-Norrin-2 mouse and its wild-type littermate show a normal 
pattern of the retinal vasculature. In vivo funduscopy and angiography was performed in cooperation with Prof. 
H. Jägle. FITC-dextran perfusion and whole mount preparation were performed with the help of Andreas 
Ohlmann. Figure published in (107). 
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Additionally, no evidence for the persistence of hyaloid vessels or capillaries of the tunica vasculosa 
lentis was observed. Furthermore, in FITC–dextran perfused retinal whole mounts the pattern of the 
vascular plexus on the inner surface of the retina was comparable in Rpe65-Norrin-2 mice and their 
wild-type littermates with no signs for retinal neovascularization or pre-retinal tufts (Figure 25).  
To investigate the vascular phenotype in more detail, the vascular endothelium of transgenic and 
wild-type animals was labeled with isolectin B4 and visualized. In addition to the already analyzed 
capillaries on the retinal surface, a regular deep and intermediate capillary plexus on the inner and 
outer aspects of the inner nuclear layer was observed (Figure 26, upper panel). Finally, the 
choriocapillaris was labeled with an antibody against plasmalemma vesicle associated protein 
(PLVAP), which is a marker for fenestrated capillaries and characteristic for the endothelium of the 
choriocapillaris (Figure 26, lower panel). Again no differences were detected between 
Rpe65-Norrin-2 mice and wild-type littermates. 
 
Figure 26: Vascular endothelial staining in Rpe65-Norrin-2 animals 
Upper panel: Isolectin B4-labeling (red) in sections through the central retina of a 2-month-old Rpe65-Norrin-2 
and wild-type mouse. The capillaries of both deep and intermediate capillary plexus (open arrows) were 
visualized. Nuclei were stained with DAPI (blue). Lower panel: Labeling of choriocapillaris endothelium (white 
arrows) with PLVAP (red) showed no differences between the Rpe65-Norrin-2 mouse and its wild-type 
littermate. Nuclei were stained with DAPI (blue). INL= inner nuclear layer; ONL= outer nuclear layer. 
Experiment published in (107), performed by Barbara Braunger. 
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2.3 The retinopathia of prematurity (ROP) model 
Additional to the neuroprotective aspect of Norrin, the angiogenic function of Norrin was analyzed 
using the ROP model. This part of the thesis was performed in cooperation with Andreas Ohlmann 
and the data are published in (106). 
To induce the vascular phenotype reflecting retinopathia of prematurity, pubs of βB1-Crystallin 
Norrin and Rpe65-Norrin-2 mice were exposed to high levels of oxygen from P7 - P12. Since the 
retina is well supplied with oxygen during this period of hyperoxia (75% oxygen), the retinal vessels 
stop to proliferate further which results in areas of vaso-obliteration. The subsequent exposure to 
normal room air leads to a relative hypoxia due to the non-perfused areas in the retina. In 
consequence of this, angiogenic factors are secreted. They induce an uncontrolled proliferation of 
the retinal vessel, resulting in preretinal tufts and leaky abnormal vessels (see also 1.3.1).  
 
Figure 27: Overexpression of Norrin protects against obliteration and loss of vessels in βB1-Crystallin Norrin 
animals 
Upper panel: FITC- dextran perfused wild-type (left) and βB1-Crystallin Norrin (right) retinae at P14 after 
induction of oxygen induced retinopathy.  
Lower panel: The area of obliterated vessels in wild-type (left) and βB1-Crystallin Norrin (right) retinae labeled 
in red. (scale bars: 500 µm). Experiment published in (73), performed by Barbara Braunger. 
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In animals with a Norrin overexpression from the lens (βB1-Crystallin Norrin), the area of obliterated 
vessels compared to wild-type littermates was significantly reduced (Figure 27, quantified in Figure 
28).  
 
 
Figure 28: Quantification of ROP induced vaso-obliteration 
The area of vaso-obliteration was quantified and plotted as percentage of total retinal area. P12, P14 and P16 
was analyzed. Data is mean ± SEM, n>10. TG= βB1-Crystallin Norrin mice; WT= wild-type controls. Experiment 
published in (106), performed by Barbara Braunger and Andreas Ohlmann. 
 
In addition to the better re-vascularisation of the superficial vascular plexus after ROP in 
βB1-Crystallin Norrin animals, their intraretinal vascularization also better compared to wild-type 
littermates. At P16, after ROP regime from P7-P12 wild-type animals showed predominantly vessels 
of the superficial plexus. In contrast, βB1-Crystallin Norrin mice showed abundant deep retinal 
capillaries (Figure 29, quantified in Figure 30). 
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Figure 29: Norrin stimulated growth of intraretinal vessels after oxygen-induced retinopathy in βB1-Crystallin 
Norrin animals 
Top: Representative FITC-labeled retinal whole mounts showing the intraretinal capillaries at P16.  
Middle: FITC- dextran labeled sagittal sections through retinal whole mount of wild-types at P16 following 
induction of oxygen-induced retinopathy. In wild-type animals, predominantly vessels of the superficial plexus 
were detectable (arrowheads).  
Bottom: FITC- dextran labeled sagittal sections through retinal whole mount of B1-Crystallin-Norrin mice at P16 
following induction of oxygen-induced retinopathy. In βB1-Crystallin Norrin mice deep retinal capillaries are 
abundant (arrows). Scale bars: 500 µm (top), 100 µm (middle and bottom). Experiment published in (106), 
performed by Barbara Braunger. 
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Figure 30: Quantification of relative area of intraretinal capillaries 
The area covered by deep retinal capillaries was quantified at P12, P14, and P16 for βB1-Crystallin Norrin mice 
and controls and plotted as percentage of total retinal area. In βB1-Crystallin Norrin animals, the area of 
intraretinal vessels was significantly higher compared to wild-type pubs. Data is mean ± SEM; n>10. TG= 
βB1-Crystallin Norrin mice; WT= wild-type controls. Experiment published in (106), performed by Barbara 
Braunger and Andreas Ohlmann. 
 
In the following, the results obtained so far, using βB1-Crystallin Norrin animals (Norrin 
overexpression in the lens), were confirmed with a second, independent mouse line, the 
Rpe65-Norrin-2 mice. In these animals Norrin is overexpressed in the retinal pigment epithelium and 
secreted into the retina (see Figure 18). In summary, Rpe65-Norrin-2 animals showed comparable 
effects to the βB1-Crystallin Norrin animals. However, the effects were less drastic in the 
Rpe65-Norrin-2 line (Figure 31 A and B). A possible explanation for this might be the different levels 
of Norrin overexpression due to the different promoters between βB1-Crystallin Norrin and 
Rpe65-Norrin-2 animals (see Figure 16).  
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Figure 31: Quantification of the influence on vessel growth in βB1-Crystallin Norrin and Rpe65-Norrin-2 
animals. 
A. The area of relative vaso-obliteration was quantified at P14. Rpe65-Norrin-2, as well as βB1-Crystallin Norrin 
animals showed a significant reduction in the area of vaso-obliteration compared to wild-type littermates.  
B. The area of relative intraretinal capillaries was quantified at P14. Rpe65-Norrin-2, as well as βB1-Crystallin 
Norrin animals showed significant more intraretinal vessels compared to wild-type littermates.  
C. The area of relative vaso-obliteration was quantified at P13. Again, βB1-Crystallin Norrin animals showed a 
significant reduction in the area of vaso-obliteration compared to wild-type littermates. However, when the 
Wnt/β-catenin- pathway was blocked in βB1-Crystallin Norrin animals using DKK1 injections into the vitreous, 
the area of vaso-obliteration significantly increased compared to uninjected βB1-Crystallin Norrin animals. Data 
is mean ± SEM; n = 10; WT= wild-type. Experiment published in (106), performed by Barbara Braunger and 
Andreas Ohlmann. 
Finally, the Wnt/β-catenin pathway was blocked after ROP using Dickkopf1 (DKK1) injections into the 
vitreous of βB1-Crystallin Norrin animals. The area of vaso-obliteration increased significantly in 
βB1-Crystallin Norrin animals, indicating that the positive influence of Norrin in the βB1 -Norrin 
animals is mediated through the Wnt/β-catenin pathway. 
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2.4 Light damage experiments 
To investigate if overexpression of Norrin in the retinal pigment epithelium and subsequent Norrin 
secretion into the retina would have neuroprotective effects on the survival of photoreceptors, light 
damage experiments were performed.  
2.4.1 Morphometric analysis 
To this end, adult (6-9 weeks old) Rpe65-Norrin-2 and wild-type littermates were placed in 
transparent plastic cages and illuminated with cool white light coming from the top, with an intensity 
of 5000 lux. The analyses were performed 7 or 14 days after light exposure. For morphometric 
analysis, horizontal semithin sections stretching from the nasal to temporal side were investigated 
(for detailed explanation, see Figure 70). As expected, the major light induced damage on 
photoreceptor cells was localized in the central retina. However, in Rpe65-Norrin-2 animals, this 
effect was reduced compared to wild-type controls (see Figure 32) and the remaining outer nuclear 
layer (ONL) in the central part of the retina in Rpe65-Norrin-2 animals was remarkably thicker 
compared to control wild-type littermates (Figure 33). 
 
Figure 32: Semithin section of light exposed Rpe65-Norrin-2 and wild-type littermates. 
Seven days after light exposure, the thickness of the ONL is noticeably reduced in the central retina, around the 
optic nerve head, whereas it is hardly thinned in the peripheral retina near the ora serrata. However, the ONL 
layer in the central retina was remained markedly thicker in Rpe65-Norrin-2 animals compared to wild-type 
controls. Experiment published in (107), performed by Barbara Braunger. 
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Figure 33: Higher magnification of the central retina after light exposure 
The white bars which embrace the ONL show the thickness of this layer and additional indicate the measure 
technique for spider diagrams.  
Left: control wild-type retina.  
Middle: light damaged wild-type animal, 7 days after light exposure.  
Right: light damaged Rpe65-Norrin-2 retina, 7 days after light exposure.  
The ONL in control animals was reduced to 2 rows of photoreceptor cell nuclei, whereas in Rpe65-Norrin-2 
animals 3 to 4 rows of cell nuclei remained. Experiment published in (107), performed by Barbara Braunger. 
For morphometric analysis, the thickness of the outer nuclear layer was measured at 21 measure 
points across the entire retina and illustrated in spider diagrams (for spider diagram creation see 
Figure 70). Statistical evaluation 7 days after light exposure of Rpe65-Norrin animals revealed a 
significant thicker outer nuclear layer at 6 measure points throughout the retina compared to their 
wild-type littermates (Figure 34), indicating a neuroprotective effect of the Norrin overexpression in 
the RPE and its secretion into the retina. 
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Figure 34: Spider diagram: ONL thickness 7 days after light exposure 
The thickness of the outer nuclear layer (ONL) was quantified at 21 measure points on horizontal sections 
stretching from the nasal to temporal side through the optic nerve head (ONH). The results are illustrated in 
this spider diagram. Data is mean ± SEM, n=6, *p<0.05, 7 days after light exposure. Experiment published in 
(107), performed by Barbara Braunger. 
14 days after light exposure this neuroprotective effect was even more pronounced. Again, the 
remaining thickness of the outer nuclear layer was quantified by morphometric analyses, followed by 
statistical evaluation. The results were plotted in spider diagrams (Figure 35). 14 days after light 
exposure Rpe65-Norrin-2 showed a significant thicker ONL at 12 measure points throughout the 
retina compared to their wild-type control littermates. Apparently, the clearance of the apoptotic 
cells after light exposure was not fully completed after 7 days, which might explain the pronounced 
effect at the later time point. 
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Figure 35: Spider diagram: ONL thickness 14 days after light exposure. 
Thickness of the outer nuclear layer (ONL), quantified at 21 measure points on horizontal sections stretching 
from the nasal to temporal side through the optic nerve head (ONH). The results are illustrated in the spider 
diagram. Data is mean ± SEM, n=6. *p<0.05, **p<0.01. Experiment published in (107), performed by Barbara 
Braunger. 
 
2.4.2 In vivo SLO and OCT imaging before and after light damage 
Laser scanning ophthalmoscopy (SLO) and optical cohaerence tomography (OCT) were used to 
visualize the fundus and retina of untreated as well as light exposed Rpe65-Norrin-2 and wild-type 
littermates in vivo. In untreated Rpe65-Norrin-2 and wild-type animals, fundus SLO (Figure 32 A, 
upper row) imaging showed a normal fundus with the regular distribution of the retinal vessels. 
Additionally, blue light fundus-autofluorescence SLO imaging was performed to investigate whether 
autofluorescence of the RPE was present (Figure 32 A, upper row, right). RPE autofluorescence is due 
to the content of lipofuscin in the RPE. Lipofuscin accumulates if photoreceptor outer segments are 
depleted incompletely. Excessive lipofuscin accumulation is characteristic for various retinal 
degenerations. Lipofuscin has an excitation spectrum between 300 - 600 nm and an emission 
spectrum of 480 - 800 nm (108–110). SLO autofluorescence showed a normal fundus in both 
untreated Rpe65-Norrin-2 animals and wild-types littermates. The optic nerve head appeared black, 
because of the absence of RPE and its lipofuscin at this very point, and the blood vessels appeared 
also dark, because of the light absorption of the blood. In contrast in light damaged animals, a huge 
area of autofluorescence was visible, indicating a thinning of the retina, which is more pronounced in 
wild-types compared to Rpe65-Norrin-2 animals (Figure 32 B, upper row, right). This result confirmed 
the morphological data points and again indicated a neuroprotective role for Norrin overexpression 
from the RPE into the retina. 
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Figure 36: In vivo SLO and OCT imaging 
A. Laser scanning ophthalmoscope (SLO – upper row) and optic coherence tomography (OCT – lower row) of 
untreated wild-type and Rpe65-Norrin-2 animals. B. Laser scanning ophthalmoscope (SLO – upper row) and 
optic cohaerence tomography (OCT – middle (central retina) and lower (mid-peripheral retina) row) of light 
exposed wild-type and Rpe65-Norrin-2 animals. The area of auto-fluorescence of the RPE is a sign for light-
induced retinopathy and was visualized with SLO imaging. In SLO in vivo imaging, wild-type animals revealed 
more auto-fluorescence compared to their Rpe65-Norrin-2 littermates. Additionally, OCT in vivo imaging 
detected a reduced ONL thickness in light exposed wild-type animals compared to transgenic Rpe65-Norrin-2 
animals in the mid-peripheral retina. The black arrows point to the ONL. GCL= ganglion cell layer, INL= inner 
nuclear layer, ONL= outer nuclear layer. OCT and SLO analysis were performed in cooperation with Prof. 
Seeliger, Tübingen. 
In untreated Rpe65-Norrin-2 and wild-type animals, optic coherence tomography (OCT) imaging 
revealed a normal layering of the retina with comparable thickness between the specimens. The ONL 
layer was well defined (Figure 36 A, second row, black arrows). Light exposed animals showed a 
markedly thinned ONL in the central retina in both, wild-type animals and Rpe65-Norrin-2 animals. 
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This phenomenon changed in the periphery (Figure 36 B, lower panel, black arrows). In 
Rpe65-Norrin-2 animals, the ONL was already visible (Figure 36 B, lower panel, black arrows), 
whereas in wild-types hardly any ONL layer was visible in OCT analysis, again indicating an intense 
occurrence of damage in wild-types compared to Rpe65-Norrin-2 animals. 
2.4.3 Functional analysis: electroretinography (ERG) analysis  
ERG analysis was used to further investigate, if the morphometric and in vivo imaging (SLO and OCT) 
differences between light exposed wild-type and Rpe65-Norrin-2 animals would also result in 
function alterations. First, ERG analysis of untreated Rpe65-Norrin-2 mice (Figure 37, blue lines) and 
their wild-type (Figure 37, black lines) littermates was performed. There was no difference apparent, 
neither under dark-adapted (scotopic), nor in light-adapted (photopic) conditions (Figure 37, top and 
middle row). However, a severe loss of a- and b-wave components of the scotopic ERGs was 
observed in wild-type animals (Figure 37, green lines, top and middle row) two weeks following light 
damage. In contrast, Rpe65-Norrin-2 mice (Figure 37, red lines, top and middle row) showed a much 
better preservation in both a- and b-waves. As expected the amplitudes were to a certain degree 
lower than before light damage. For photopic conditions comparable results were observed. After 
statistical analysis (Figure 37, lower row) Rpe65-Norrin-2 mice revealed significantly better 
preservation of both the maximal a-wave, as well as the b-wave of the specific rod system and the 
specific cone system compared to wild-type mice. This results again indicated that overexpression of 
Norrin protects both rod and cone photoreceptors from light damage. 
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Figure 37: Functional ERG analysis 
Top: Color legend of the 4 different experimental groups and representative single flash ERG recordings. 
Middle: Evaluation of single flash ERG b-wave amplitudes, scotopic (left) and photopic (right) in Box-and-
whisker plots. The boxes indicate the 25 and 75% quantile range; whiskers indicate the 5 and 95% quantiles; 
and the asterisks indicate the median of the data. (n=4 each).  
Bottom: Box-and-whisker plots of scotopic ERG b-wave amplitudes at −2.0 log cd s/m2 (left), scotopic ERG a-
wave amplitudes at 1.5 log cd s/m2 (middle), and photopic ERG b-wave at 1.5 log cd s/m2 (right). (n.s. = not 
significant, * p<0.01, ** p<0.001; Mann–Whitney rank sum test). (n=4 each). The ERG analysis was performed 
in cooperation with Prof. Seeliger, Tübingen. Figure published in (107). 
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2.4.4 Analysis of the visual cycle 
A normal function of the visual cycle is essential to be able to set a light damage (see 1.1.2.2). To 
analyze the state of the visual cycle, rhodopsin Western blots and immunohistochemical staining 
were performed. The total amount of rhodopsin, determined with Western blot analysis and 
immunohistochemical staining, was not altered in Rpe65-Norrin-animals compared to their control 
wild-type littermates (Figure 38). Immunohistochemical staining showed a strong immunoreactivity 
for rhodopsin in the photoreceptor segments and the retinal pigment epithelium in both, 
Rpe65-Norrin-2 animals and wild-types. 
 
Figure 38: Rhodopsin: Western blot and immunohistochemistry 
A. Western blot analysis for rhodopsin. Gapdh was used as loading control.  
B. Immunohistochemical staining for rhodopsin (green). Cell nuclei are stained with Dapi (blue). 
 
Additionally, western blot analyses for RPE65 protein were performed. RPE65 protein is an essential 
protein in the visual cycle (see 0). There was no difference in the protein level of RPE65 protein in 
Rpe65-Norrin-2 animals compared to controls (Figure 39). The results obtained so far did not show a 
difference in the amount of two major factors of the visual cycle (rhodopsin and RPE65). The total 
amount of them did not vary between the Rpe65-Norrin-2 and wild-type animals. 
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Figure 39: RPE65 (protein) Western blot 
Western blot analysis for RPE65 protein in posterior halves of the eye. Tissue contained retina, RPE and sclera. 
Gapdh was used as loading control. 
Furthermore, the rhodopsin recovery kinetics after illumination in Rpe65-Norrin-2 and wild-type 
littermates was analyzed. Here Rpe65-Norrin-2 animals showed a significant reduction in the capacity 
of rhodopsin recovery after illumination in the retinae harvested immediately after light exposure, 3h 
and 6h after light exposure with a meantime recovery period in the dark (Figure 40).  
 
Figure 40: Rhodopsin recovery kinetics in darkness 
 Rpe65-Norrin-2 animals (dark: square and triangle) show a significant reduced capacity of rhodopsin recovery 
compared to wild-types (light grey: square and triangle). The content of rhodopsin in retinal samples was 
investigated at 4 different time-points: un-treated, only dark adapted animals (0 h, upper symbols), animals 
killed direct after light exposure (0 h, lower symbols), or 3 h and 6 h after light exposure. The two curves only 
highlight the approximate progress of the recovery kinetic. The amount of rhodopsin was investigated using 
photometer analysis at 500 nm wave length as described in 5.1.6.8. Square: data point of the single animals, 
triangle: mean and SEM (per time-point); n ≥ 4 per time-point; *p<0.05;**p<0.01. 
 
Taken together, Rpe65-Norrin-2 animals showed normal protein expression levels of RPE65 and 
rhodopsin in Western Blot analysis. However, their rhodopsin recovery kinetic in darkness was 
impaired 
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2.4.5 Light exposure and apoptosis 
Subsequently, TUNEL labeling, which indicates apoptotic cells, was performed to investigate if the 
differences in ONL thickness between Rpe65-Norrin-2 mice and their wild-type littermates might be 
the result of a different amount of photoreceptors entering apoptotic cell death following light 
exposure. Numerous TUNEL-positive cells were detected in the central retina in both Rpe65-Norrin-2 
mice and their wild-type littermates. While some TUNEL-positive cells were detected in the 
peripheral retina of wild-type mice, only a very small number of apoptotic cells was detected in 
Rpe65-Norrin-2 mice the in the peripheral retina (Figure 41).  
 
Figure 41: Norrin overexpression protects photoreceptors from light damage.  
Horizontal TUNEL stained (green) sections of retinae 30 h after light damage. Nuclei are stained with Dapi 
(blue). Boxed areas in the merged picture indicate positions of panels in Figure 42 A. The distribution of the 
photoreceptor apoptosis throughout the retina with the major amount of apoptosis in the central part and less 
in the peripheral retina is characteristic for light damage. Experiment published in (107), performed by Barbara 
Braunger. 
Next, the total number of TUNEL-positive nuclei in mid-horizontal sections in the outer nuclear layer 
was counted and normalized to the area of the outer nuclear layer. 1.76 ± 0.013 cells per 1000 μm2 
area outer nuclear layer were counted in wild-type mice versus 1.23 ± 0.066 cells per 1000 μm2 in 
Rpe65-Norrin-2 transgenic mice (p<0.05) (Figure 42 A and B). These results were further validated 
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with a second independent assay. An ELISA that determined the relative amounts of cytoplasmic 
histone-associated DNA fragments (mono- and oligonucleosomes) was used to this end. The rate of 
cytoplasmic nucleosomes was 1.79 ± 0.24-fold higher in wild-type animals when compared to 
Rpe65-Norrin-2 mice (p<0.05) (Figure 42 C). 
  
Figure 42: Norrin overexpression protects photoreceptors from light damage induced apoptosis 
A. Higher magnification of the central retina (indicated area in Figure 41). Apoptotic cells were TUNEL labeled 
(green) 30 h after light exposure. Cell nuclei are labeled with Dapi (blue). B. Quantification of TUNEL positive 
cells per 1000 µm² ONL. The number of TUNEl positive cells is significant reduced in Rpe65-Norrin-2 animals.  
C. Cell death detection ELISA 30 h after light exposure. Rpe65-Norrin-2 animals showed significant less amounts 
of free histones compared to wild-types.  
Data is mean ± SEM; TUNEL: n= 6, ELISA: n≥ 12; *p<0.05 . INL= inner nuclear layer, ONL= outer nuclear layer. 
Experiment published in (107), performed by Barbara Braunger. 
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2.4.6 Wnt-/β-catenin signaling and Norrin mediated neuroprotection 
To analyze if the neuroprotective effect in Rpe65-Norrin-2 animals might be mediated through 
Wnt-/β-catenin signaling, Dickkopf-1 (DKK1), an inhibitor of the Wnt-/β-catenin pathway, was 
injected in the vitreous of both Rpe65-Norrin-2 and wild-type littermates. In an initial experiment 
Western blotting for β-catenin was performed to assay the retinal protein levels in Rpe65-Norrin-2 
animals and control littermates (Figure 43 A). Densitometric analysis of Western blots revealed a 
significant (p<0.05) increase in the amount of β-catenin in sham injected (PBS) Rpe65-Norrin-2 mice 
compared to wild-types (Figure 43 B). This result is quite comparable to the effects seen in 
uninjected animals (Figure 19). However, DKK1 injection reduced β-catenin protein levels 
significantly in Rpe65-Norrin-2 mice to levels seen in wild-type animals, whereas the injection of 
DKK1 into the vitreous of wild-type mice did not cause any alteration in the amounts of retinal 
β-catenin (Figure 43 B). 
 
Figure 43: β-catenin Western blot analysis after DKK1 injections 
A. β-catenin Western blot analysis of PBS and DKK1 injected eyes.  
B. Densitometric analysis of Western blots for β-catenin levels in retinae of DKK1- or PBS-injected wild-type and 
Rpe65-Norrin-2 eyes.  
Data is mean ± SEM, n≥ 4, *p<0.05. Experiment published in (107), performed by Barbara Braunger. 
Subsequently, Wnt-/β-catenin signaling was blocked by DKK1 injections in Rpe65-Norrin-2 mice and 
wild-type littermates, 12 h before and 2 or 4 days after light exposure. One eye was injected with 
DKK1, while the contralateral eye was sham injected with PBS only. 7 days after light exposure, the 
eyes were harvested and semithin sections were analyzed using spider diagrams. In general, in light 
damaged, PBS-injected eyes, the thinning of the ONL was less severe than in non-injected eyes. 
However, the outer nuclear layer in the central retina of PBS-injected Rpe65-Norrin-2 eyes was still 
significantly thicker than the ONL of the PBS-injected wild-type littermates (Figure 44, upper panel).  
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Figure 44: Spider diagrams: light exposure and Wnt/β-catenin signaling inhibition 
Top: Spider diagram reflecting the thickness of the outer nuclear layer (ONL) of sham injected (PBS) wild-type 
and Rpe65-Norrin-2 mice 7 days after light exposure.  
Middle: Spider diagram of the outer nuclear layer (ONL) thickness of DKK1- or PBS-injected contralateral eyes 
of Rpe65-Norrin-2 mice.  
Bottom: Spider diagram of the outer nuclear layer (ONL) thickness of DKK1- or PBS-injected fellow eyes of 
wild-type littermates. Data is mean ± SEM, n= 6; *p<0.05 . Experiment published in (107), performed by 
Barbara Braunger. 
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After comparing the outer nuclear layer thickness of PBS and DKK1 injected eyes of Rpe65-Norrin-2 
animals, the DKK1 injected retinae appeared more affected by light exposure than the PBS injected 
fellow eye, especially in the central retina. This indicated that the neuroprotective effect observed in 
Rpe65-Norrin-2 animals following light exposure might be mediated through an activation of the 
Wnt-/β-catenin pathway.  
When comparing the outer nuclear layer thickness of PBS and DKK1 injected eyes of wild-types, there 
was no difference, neither in the central, nor in the peripheral part of the retina. This result was not 
surprising, since the Dkk-1 injections in wild-types did not reduce the β-catenin level significantly (see 
Figure 43). 
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2.5 Neuroprotective factors 
2.5.1 Transgenic Norrin overexpression and neuroprotective factors 
The previous results (Figure 44) showed that the neuroprotective effect of Norrin overexpression is 
at least partly mediated through an activation of the Wnt-/β-catenin signaling. In the following, the 
expression profiles of various neuroprotective factors were analyzed to investigate if the activation of 
the Wnt-/β-catenin signaling would lead to an increased expression of neuroprotective factors. To 
this end, quantitative real-time RT-PCR was performed of retinal RNA samples from untreated (no 
light damage) Rpe65-Norrin-2 and wild-type littermates. Several neuroprotective factors like 
leukemia inhibitory factor (Lif), fibroblast growth factor 2 (FGF2), brain derived neurotrophic factor 
(Bdnf), lens epithelium derived growth factor (Ledgf), ciliary neurotrophic factor (Cntf) and pigment 
epithelium derived growth factor (Pedf) were not differentially regulated. On the other hand, factors 
like glial fibrillary acidic protein (Gfap), endothelin2 (Edn2) and endothelin receptor type B (Ednrb) 
were significantly upregulated in Rpe65-Norrin-2 animals compared to their wild-type controls 
(Figure 45). 
 
Figure 45: Realtime RT-PCR of untreated Rpe65-Norrin-2 and wild-type animals 
Quantitative real-time RT-PCR for mRNA for neuroprotective factors: Gfap, Edn2, Ednrb, Lif, Fgf2, Bdnf, Ledgf, 
Cntf and Pedf in untreated adult wild-type and Rpe65-Norrin-2 retinae. Data is mean ± SEM, n≥ 6, **p<0.01, 
*p<0.05. Experiment published in (107), performed by Barbara Braunger. 
To gain more insight into the localization of the dysregulated factors GFAP, EDN2 and EDNRB, 
immunohistochemical staining were performed. GFAP is a marker for astrocytes and activated Müller 
glia cells. As expected, staining for GFAP was detected on top of the retinal ganglion cell layer in 
wild-type mice, whereas in Rpe65-Norrin-2 animals, an intense immunoreactivity was detected along 
the inner retinal surface and an additional labling in the inner plexiform layer (Figure 46, upper 
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panel). Double immunohistochemical staining with antibodies against GFAP and glutamine 
synthetase (GS), a marker for Müller glia cells, revealed a partly overlap of the immunoreactivity at 
the inner retinal surface, but not a complete overlap layer (Figure 46, lower panel). This indicated an 
expression of GFAP in both Müller glia cells, especially their end feet, and astrocytes. 
 
Figure 46: Immunohistochemical staining for GFAP in Rpe65-Norrin-2 animals 
Top: GFAP (green) immunohistochemical staining of an adult wild-type retina. Cell nuclei were stained with 
DAPI (blue). Wild-type animals showed a discrete patchy staining in the inner side of the retina, whereas the 
Rpe65-Norrin-2 animal showed a distinct immunolabeling at the inner side of the retina and in the outer 
plexiform layer.  
Bottom: GFAP and GS double labeling. Rpe65-Norrin-2 animals displayed the regular pattern of GS Müller glia 
staining with a distinct staining along the elongated glia processes stretching through the entire retina front the 
inner limiting membrane to the outer limiting membrane. The GFAP double labeling showed a partly overlap 
with the GS staining on the inner side of the retina, indicating an GFAP staining in both, Müller glia end feet and 
astrocytes. INL= inner nuclear layer; ONL= outer nuclear layer. Experiment published in (107), performed by 
Barbara Braunger. 
Immunohistochemical staining for EDN2 revealed a discrete immunolabeling at the ganglion cell 
layer and in the retinal pigment epithelium (RPE). In Rpe65-Norrin-2 animals, the immunolabeling 
was particularly strong in the ganglion cell layer with an additional intense staining of the 
photoreceptor inner segments and in the retinal pigment epithelium (RPE) and an additional patchy 
immunostaining in the outer and inner plexiform layer (IPL/OPL). 
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Figure 47: Immunohistochemistry of EDN2 in Rpe65-Norrin-2 animals 
Wild-type animals showed a discrete immunolabeling in the ganglion cell layer and the retinal pigment 
epithelium. Rpe65-Norrin-2 animals had an additional homogenous staining of the photoreceptor inner 
segment and a patchy distribution in the inner and outer plexiform layer and a more intense labling in the 
ganglion cell layer. PIS= photoreceptor inner segments; GCL= ganglion cell layer; RPE= retinal pigmented 
epithelium. Experiment published in (107), performed by Barbara Braunger. 
In wild-type mice, endothelin receptor type B (EDNRB) immunoreactivity was detectable in the inner 
segments of the photoreceptors, while Rpe65-Norrin-2 animals had an additional staining for EDNRB 
in the ganglion cell layer. 
Double labeling experiments for EDNRB and GS revealed no co-localization. Additionally, the double 
labeling experiments with EDNRB and rhodopsin, a marker for rod photoreceptors, showed no 
co-localization in the inner segments of the photoreceptors. However, co-labeling for EDNRB and 
peanut agglutinin (PNA), a lectin that labels the interphotoreceptor matrix that sheaths cone 
photoreceptor inner and outer segments (111), showed an overlap, which strongly indicates that 
EDNRB is localized on cone photoreceptor outer segments. In Rpe65-Norrin-2 retinae, the EDNRB 
staining in general was more intense compared to wild-types and it co-localized with GS, which 
strongly indicated a co-localization with Müller glia end feet (Figure 48). Similar to the labeling in 
wild-types, co-labeling EDNRB with PNA in Rpe65-Norrin-2 animals revealed a co-localization, 
indicating its localization on cone photoreceptor cells. Yet, the PNA signal was more extended to the 
outer segments in Rpe65-Norrin-2 compared to wild-type labeling (Figure 49). 
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Figure 48: Immunohistochemical staining of EDNRB and co-labeling with rhodopsin and PNA in wild-type 
mice 
Double immunohistochemical staining in wild-type animals for EDNRB (green) and either GS (red), or rhodopsin 
(red), or PNA (red). Nuclei were stained with DAPI (blue). Immunoreactivity for EDNRB was detectable in the 
inner segments of the cone photoreceptors (arrows) that are negative for GS and rhodopsin, but label positive 
for PNA. GCL= ganglion cell layer; PIS= photoreceptor inner segments; RPE= retinal pigmented epithelium. 
Experiment published in (107), performed by Barbara Braunger. 
 
 
Figure 49: Immunohistochemical staining of EDNRB and co-labeling with PNA in Rpe65-Norrin-2 mice 
Staining for EDNRB was more intense in Rpe65-Norrin-2 retinae than in wild-type and was additionally seen 
along the inner surface of the retina where it co-localized with GS. This strongly indicated its localization in 
Müller cell end-feet (open arrow). Staining for EDNRB was also seen in GS-negative, but PNA-positive cone 
photoreceptor inner and outer segments (white arrows). GCL= ganglion cell layer, PIS= photoreceptor inner 
segments; PAS= photoreceptor outer segments; RPE= retinal pigmented epithelium. Experiment published in 
(107), performed by Barbara Braunger. 
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So far, the data show that Norrin overexpression from the retinal pigment epithelium leads to a 
significant upregulation of the neuroprotective factor EDN2 and its receptor EDNRB (Figure 45). This 
factor is localized in the inner segments of the photoreceptors, the ganglion cell layer, the inner and 
outer plexiform layer and the retinal pigment epithelium. The receptor is localized on the 
photoreceptor inner and outer segments and the Müller glia end feet at the innermost layer of the 
retina. The upregulation of GFAP indicates an activation of Müller glia cells and astrocytes, most 
likely due to the overexpression of Norrin and its higher levels in the retina (Figure 17). 
2.5.2 Correlation between Norrin induced Wnt/β-catenin activation, EDN2 upregulation 
and light induced apoptosis 
Next, the correlation between EDN2 upregulation and Wnt/β-catenin signaling was analyzed. To this 
end, DKK1 was injected into the vitreous before taking the retinae for mRNA analysis. Prior to the 
actual experiments the influence of vitreal injections themselves on the expression levels of 
neuroprotective factors of interest were investigated. To this end the mRNA expression levels of 
Ledgf, Edn2 and Bdnf were compared from sham injected (PBS) wild-types retinae and control (no 
injection) wild-types. The injection led to a significant increase in the expression of Ledgf and Edn2 
but not Bdnf (Figure 50). In the following inhibitor injected eyes were always compared with sham 
injected fellow eyes. The injection induced upregulation was therefore comparable in both eyes and 
detected differences are most likely due to the inhibitor.  
 
Figure 50: Influence of injections on the expression levels of Ledgf, Edn2 and Bdnf 
Quantitative realtime RT-PCR of wild-types control retinae (no injection) and PBS injected fellow eyes. Control: 
n= 3, PBS: n= 7; **p<0.01.  
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Wnt/β-catenin inhibition lead to a significant reduction of the Edn2 expression in the retinae of 
Rpe65-Norrin-2 animals, which strongly indicated a correlation between the Norrin mediated 
activation of Wnt/β-catenin signaling and retinal Edn2 upregulation (Figure 51). 
 
Figure 51: Wnt/β-catenin signaling and Edn2 expression (DKK1 injections)  
Quantitative real-time RT-PCR for Edn2 mRNA in the retinae of wild-type and Rpe65-Norrin-2 mice following 
intravitreal injection of DKK1. The mean value obtained with RNA from PBS-injected wild-type animals was set 
at 1. Data is mean ± SEM, wild-type: n= 3, Rpe65-Norrin-2: n≥ 8, *p<0.05. Experiment published in (107), 
performed by Barbara Braunger. 
Subsequently, the correlation between Edn2 upregulation and apoptosis was analyzed. To achieve 
this, EDN2-signaling was inhibited prior to light exposure by using BQ788, an antagonist for 
endothelin receptor type B (EDNRB). BQ788 was injected into the vitreous before light exposure and 
the number of apoptotic (TUNEL positive) cells was investigated 30 h after light exposure. 
Consequently, the inhibition of EDN2 signaling led to a significant increase in the number of TUNEL 
positive cells in the retinae of Rpe65-Norrin-2 animals compared to the sham (5% DMSO in PBS) 
injected fellow eyes (Figure 52). 
Taken together the obtained data so far indicate a correlation between Norrin induced 
Wnt/β-catenin signaling activation (Figure 19), which lead to an upregulation of EDN2 (Figure 45 and 
Figure 51) in the retinae of Rpe65-Norrin-2 animals, which in turn protect these animals from light 
induced apoptosis (Figure 52). 
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Figure 52: Light damage induced apoptotic cell death following End2 signaling inhibition (BQ788) 
Quantitative TUNEL analysis, 30 h following light damage and intravitreal injection of BQ788 (left eye) or 5% 
DMSO in PBS (right eye, control). Data is mean ± SEM, n≥ 4, *p<0.05. Experiment published in (107), 
performed by Barbara Braunger.  
Neuroprotective factors like LIF, EDN2 and FGF2 are well described in the context of light exposure 
and neuroprotection (99,100,112,113). Hence, the levels of these and other neuroprotective factors 
following light exposure were analyzed. Comparable to published results, a significant increase in the 
expression of both Lif and Edn2 in wild-type retinae after light damage (Figure 53) was observed. 
Surprisingly, the increase in Lif and Edn2 expression was significantly (p<0.05) less in light-damaged 
Rpe65-Norrin-2 animals (Figure 53).  
 
Figure 53: Expression levels of Lif and Edn2 before and after light exposure. 
Realtime RT-PCR for Lif and Edn2 in wild-type (wt) and Rpe65-Norrin-2 (R–N-2) retinae before and 6 h after 
light damage. The mean value of the untreated (no light) wild-type animals was set at 1. Data is mean ± SEM, 
n≥ 5, *p<0.05, **p<0.01. Experiment published in (107), performed by Barbara Braunger. 
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GFAP, a marker for activated Müller glia cells, was significantly upregulated following light exposure 
in wild-types and Rpe65-Norrin-2 animals, but when comparing light exposed wild-types with light 
exposed Rpe65-Norrin-2 animals, Rpe65-Norrin-2 animals showed a significant lower induction of 
Gfap (Figure 54). FGF2, a marker expressed from Müller glia cells following light damage, was 
significantly upregulated in both wild-types and Rpe65-Norrin-2 animals following light exposure 
(Figure 54).  
 
Figure 54: Expression levels of Gfap and Fgf2 before and after light exposure 
Realtime RT-PCR for Gfap and Fgf2 in wild-type (wt) and Rpe65-Norrin-2 (R–N-2) retinae before and 6 h after 
light damage. Mean ± SEM, n≥ 5, *p<0.05, **p<0.01. The mean value from untreated (no light) wild-type 
animals was set at 1. Experiment published in (107), performed by Barbara Braunger. 
When other neuroprotective factors like Cntf and Pedgf were analyzed after light exposure, there 
were no differences between Rpe65-Norrin-2 and wild-types. (Cntf: wild-types: 1 ± 0.31, n= 6, 
Rpe65-Norrin-2: 0.71 ± 0.15, n= 5, p= 0.50; Pedgf: wild-types: 1 ± 0.45, n= 8, Rpe65-Norrin-2: 
0.27 ± 0.04, n = 5, p = 0.27 (mean ± SEM)). 
2.5.3 Brain-derived neurotrophic factor and the protective effects of Norrin 
However, when expression levels of Bdnf and Ledgf were investigated, significant differences in the 
amounts of mRNA between light-damaged wild-type and transgenic mice were detected. Bdnf and 
Ledgf levels were significantly lower (p<0.01) in light-damaged wild-type mice as compared to 
untreated wild-type mice, while the expression of Bdnf was significantly higher (p<0.05) in light-
damaged Rpe65-Norrin-2 mice as compared to untreated Rpe65-Norrin-2 mice (Figure 55). These 
differences in both Bdnf and Ledgf levels were most probably due to a stabilization or upregulation 
respectively of their mRNA in Rpe65-Norrin-2 animals after light exposure.  
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Figure 55: Expression levels of Bdnf and Ledgf before and after light exposure 
Realtime RT-PCR for Bdnf and Ledgf in wild-type (wt) and Rpe65-Norrin-2 (R–N-2) retinae before and 6 h after 
light damage. Mean±SEM, n≥ 5, *p<0.05, **p<0.01. The mean value from untreated (no light) wild-type 
animals was set at 1. Experiment published in (107), performed by Barbara Braunger. 
This data point was of high interest, because Norrin overexpression in Rpe65-Norrin-2 animals led to 
an upregulation of the neuroprotective factor Bdnf (Figure 55) without involving the upregulation of 
the neuroprotective key factors Lif or Fgf2 (Figure 53), factors that are described to consitute an 
instrinsic protective signaling mechanism in the mouse retina following light exposure (100). 
In the following we focused on the neuroprotective factor BDNF. This factor is expressed in retinal 
ganglion cells as well as transported retrograde from the superior colliculus back into the retina. The 
protein level of BDNF in Rpe65-Norrin-2 and wild-type retinae was investigated using western blot 
analysis 6h after light exposure. The densitometric analysis showed a significant upregulation of 
BDNF in Rpe65-Norrin-2 animals compared to wild-types following light exposure (Figure 56). 
 
Figure 56: Western Blot analysis of BDNF protein levels following light exposure 
BDNF (14 kDa) Western blot analysis and relative densitometry in wild-type and Rpe65-Norrin-2 (Rpe65-N-2) 
retinae 6 h after light damage. Data is mean ± SEM, n≥ 7, *p<0.05. Experiment published in (107), performed by 
Barbara Braunger. 
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Next, immunohistochemical staining for BDNF was performed to assay the protein localization. 
Wild-type mice showed no specific signal in their retinae 6 h after light exposure, while 
light-damaged Rpe65-Norrin-2 mice revealed a positive immunoreactivity for BDNF throughout the 
entire retina, which was especially intense on the retinal surface (Figure 57, upper panel). Double 
labeling experiments with antibodies against either BDNF and GFAP (astrocytes, activated Müller 
glia), or BDNF and GS (Müller glia) indicated that BDNF immunoreactivity in the innermost layer of 
the retina was localized to glia cells (Figure 57, lower two panels).  
 
Figure 57: Immunohistochemical staining of BDNF after light damage 
Immunohistochemistry of BDNF (green) 6 h after light damage. Nuclei are stained with DAPI (blue). No 
immunoreactivity for BDNF was observed in the wild-type (top row) animals. However, the Rpe-65-Norrin-2 
mice showed immunolabeling throughout the entire retina (second row), which was especially intense on the 
retinal surface (arrows). Double labeling of Rpe65-N-2 (R–N-2) retinae with antibodies against BDNF and GFAP, 
or BDNF and GS showed partial co-localization (arrows) and indicates that BDNF immunoreactivity localizes to 
glial cells. GCL= ganglion cell layer; INL= inner nuclear layer; ONL= outer nuclear layer. Experiment published in 
(107), performed by Barbara Braunger. 
 
To analyze if there is a possible underlying correlation between the higher amounts of BDNF in light-
damaged Rpe65-Norrin-2 mice and the increase in Wnt/β-catenin and EDN2 signaling, mice were 
treated with intravitreal injections of DKK1 (inhibition of Wnt/β-catenin signaling), or BQ788 
(inhibition of EDN2 signaling), prior to light damage. In light damaged Rpe65-Norrin-2 mice both 
injections caused a significant lower Bdnf expression, while no differences were observed in injected 
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and light-damaged wild-type mice (Figure 58). Concerning the retinal expression level of Ledgf, 
neither the injection of DKK1, nor of BQ788 caused any significant differences (Figure 58).  
 
Figure 58: Bdnf and Ledgf in the context of Wnt/β-catenin and EDN2 signaling. 
Left: Quantitative real-time RT-PCR of mRNA for Bdnf and Ledgf in Rpe65-Norrin-2 retinae 6 h after light 
exposure and intravitreal injection of BQ788 (left eye) or DMSO (right eye). Data is mean ± SEM, n= 8, *p<0.01. 
Right: Quantitative real-time RT-PCR of mRNA for Bdnf and Ledgf in Rpe65-Norrin-2 retinae 6 h after light 
exposure and intravitreal injection of DKK1 (left eye) or PBS (right eye). Data is mean ± SEM, n= 16, * p<0.05. 
Experiment published in (107), performed by Barbara Braunger. 
Receptor-binding of BDNF activates the PI3K-Akt signaling pathway to mediate its neuroprotective 
characteristics. Therefore, the amounts of Akt/phospho-Akt (pAkt) were investigated using Western 
blot analysis of Rpe65-Norrin-2 retinae and wild-types after light-damage. Densitometric analysis 
showed an almost 4-fold (p<0.05) higher amount of phosphorylated Akt in Rpe65-Norrin-2 animals 
compared to wild-type littermates after light exposure (Figure 59). 
 
Figure 59: Akt and pAkt protein levels following light exposure. 
Left: Western blot analysis for Akt and pAKT of wild-type and Rpe65-Norrin-2 retinae 6 h after light damage. 
Right: Relative densitometry for pAKT levels. Data is mean ± SEM, n≥ 7, * p<0.05. Experiment published in 
(107), performed by Barbara Braunger. 
One possible explanation for the elevated BDNF protein level in Rpe65-Norrin-2 animals might be a 
reduced degradation of this factor. A first hint towards this was the significant reduced expression of 
Smurf1, an ubiquitin ligase, in untreated Rpe65-Norrin-2 animals (Figure 60) as well as in light 
damaged animals (data not shown). 
 
 
Results 
 
65 
 
 
Figure 60: Smurf1 expression levels in Rpe65-Norrin-2 animals 
Quantitative realtime RT-PCR for Smurf1 in retinae of untreated Rpe65-Norrin-2 animals and wild-types. Data is 
mean ± SEM, n> 5, p=0.04.  
In summary, the analyzes of the neuroprotective factors in the retina before and after light exposure 
strongly indicated that the Norrin mediated neuroprotective effect was most likely due to an 
constitutive upregulation of EDN2 (see Figure 45), which resulted in an upregulation or stabilization 
(see Figure 55) of the neuroprotective factors Bdnf and Ledgf in the light damaged retinae.  
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3 Discussion 
3.1 Norrin in the context of neuroprotection 
The hypothesis that Norrin might have neuroprotective effects originated from the observation that 
Norrin knockout mice Ndpy/- had a reduction in retinal ganglion cell number (74) and the fact that 
mice that overexpressed Norrin in the lens (Nor-29) had more retinal ganglion cells and a higher 
number of cells in the developing retina (73). An in vivo study showed that intravitreal injections of 
recombinant human (rh) Norrin were neuroprotective for retinal ganglion cells, using the NMDA 
induced excitotoxic cell death model (80). This study showed that the neuroprotective effects were 
mediated through Wnt/β-catenin signaling, followed by an upregulation of neuroprotective factors 
(80).  
The aim of the current study was to investigate, if a constitutive overexpression of Norrin would have 
neuroprotective effects on photoreceptor cells in the light damage model.  
3.1.1 Characterization and morphology of Rpe65-Norrin-2 mice 
We obtained 2 transgenic founder lines, but only Rpe65-Norrin-2 animals did show a positive signal 
in Northern and Southern Blot analysis. Despite the overexpression of Norrin in the Rpe65-Norrin-2 
line, these transgenic animals did not show an obvious phenotype. In contrast, another transgenic 
mouse line, which overexpresses Norrin in the lens (Nor-29), had a significantly higher number of 
retinal ganglion cells and cell nuclei of neurons in the developing retina and a persistence of the 
hyaloid artery. This discrepancy is most likely explained through the different developmental 
promoter activation and their efficiency and/or the localization of the overexpression. The very 
strong, lens specific βB1-Crystallin promoter induces expression at E12.5 (114,115), while the 
moderate strong Rpe65 promoter initiates expression not before E18 (116–118). The differences in 
promoter efficiency became obvious, when samples from the lens specific βB1-Crystallin Norrin 
animals were used as positive control in Northern Blot analysis of the Rpe65-Norrin-2 eyes, and the 
Northern blot showed exactly this difference in Norrin RNA expression that is driven either through 
Rpe65 or βB1-Crystallin promoter. The higher number of retinal neurons in Nor-29 animals was 
clearly demonstrated to be due to an increased neuronal proliferation in the retina during embryonic 
development (E14.5) (73), a time point, when Norrin overexpression driven by the RPE65 promoter 
in Rpe65-Norrin-2 animals is not active yet. In vitro experiments showed that recombinant human 
(rh) Norrin added to RGC-5 (retinal ganglion cells) cell cultures resulted in a higher number of 
surviving cells (20%) indicating a more direct effect of Norrin on cell survival (80). The fact that 
Rpe65-Norrin-2 mice did not show an alteration in neuronal cell number might additionally be due to 
a different sensitivity to Norrin of photoreceptor cells in contrast to retinal ganglion cells, since the 
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Norrin secretion from the RPE is mostly localized around the photoreceptor cells reaching only to the 
outer plexiform layer. 
Taken together, the characterization of the Rpe65-Norrin-2 mice demonstrated a successful 
overexpression of Norrin and its secretion from the RPE into the retina. The morphology of these 
animals was not altered. 
3.1.2 Norrin and light exposure 
Light damage experiments were used to induce cell death specifically to photoreceptors (97). We 
used cool white light at an intensity of 5000 lux for a maximum duration of 1 hour. These damage 
conditions were defined in dose-effect studies at the very beginning of this thesis (data not shown). 
In comparison to the light regimes used in other laboratories (illumination up to 24 h (122), 
intensities up to 15000 lux (37)), ours is rather mild. However, we observed an intense signal increase 
in the TUNEL labeling and strong effects on the retinal structure. The effects are more pronounced 
compared to light damages using e.g. another albino strain, the Balb/c mice. Different susceptibility 
of mouse strains to light exposure is well reported (123), but to our understanding, the heterozygous 
rd1 mutation (originating from the FVB/N) present in our F1 generation of FVB/N;CD1 animals might 
additionally boost the effect.  
Following light exposure, the transgenic Norrin overexpressing animals showed a thicker outer 
nuclear layer, less apoptosis following light exposure, a better preserved retinal function in the ERG 
analysis and less autofluorescence in SLO in vivo imaging, which correlates with retinal degeneration. 
Taken together, the results strongly indicate a neuroprotective role of Norrin on photoreceptor cells.  
Similar observations have been made for retinal ganglion cells using the model of NMDA-induced 
excitotoxic cell death. Here they showed protective effects of intravitreal injections with rh Norrin in 
combination with NMDA (80). In our damage model the neuroprotective effect in the transgenic 
animals was most likely due to the constitutive overexpression of the Norrin and its secretion into 
the retina.  
Yet, a minor influence of the impaired visual cycle cannot be entirely excluded. However, this 
contribution seems rather unlikely, since ERG analysis of the untreated animals did not reveal any 
significant differences between Rpe65-Norrin-2 and wild-types. ERG responses are very sensitive to 
impairments of the visual cycle, hence ERG is used to monitor the effect of visual cycle modification 
that are now for the first time tested in a pharmacological study (124,125). Briefly, in this study 
ACU-4429 (Emixustat), a small-molecule visual cycle modulator that inhibits the RPE65 isomerase 
complex, prevented the accumulation of A2E (N-retinyledin-N-retinylethanolamin) in a mouse model 
of retinal degeneration (124). A2E is a major fluorophore component of lipofuscin, which represent a 
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biomarker for cellular aging and is of interest especially in the context of age related macular 
degeneration (126,127). Taken together, we did not observe significant ERG alterations in our 
untreated animals, indicating that the visual cycle is not modified to an extent of any greater 
biological relevance; hence a contribution of this to the results of our light damage experiments 
seems rather unlikely. 
In summary, the transgenic overexpression of Norrin attenuated light induced photoreceptor 
damage, strongly indicating a neuroprotective role of Norrin for photoreceptor cells. 
3.1.3 Norrin, Wnt/β-catenin and Edn2 signaling 
Norrin activates Wnt/β-catenin signaling through specific binding to the Frizzled4 receptor (Fz4) (84). 
In the retina, the Fz4 receptor is expressed in all layers, but most prominently in the outer nuclear 
layer (ONL) and the inner segments of the photoreceptors (128). In Western blot analysis of 
transgenic animals, we observed significant elevated levels of retinal β-catenin and confirmed the 
activation of retinal Wnt/β-catenin signaling in all retinal layers using TOPGAL reporter mice. 
Wnt/β-catenin was shown to have neuroprotective effects (129). Therefore, the continuously active 
Wnt/β-catenin signaling in Rpe65-Norrin-2 animals is likely an essential component of Norrin's 
neuroprotective effects on photoreceptor survival. Dkk1 injections which successfully reduced 
β-catenin levels in the retina, resulting in an effective inhibition of the retinal Wnt/β-catenin 
pathway, markedly reduced the protective effects of the transgenic animals in the light damage 
experiments.  
Untreated Rpe65-Norrin-2 animals showed a significant upregulation of the Müller cell activation 
marker Gfap, the neuroprotective factor Edn2 and its receptor Ednrb. GFAP is expressed in astrocytes 
and Müller glia cells when they become reactive. Double labeling experiments with the Müller glia 
marker glutamine synthetase (GS) showed that the GFAP signal is localized in astrocytes and Müller 
glia cells. In Müller cells it is most pronounced in their end feet at the inner limiting membrane. Edn2 
is upregulated after light damage, as well as in mouse models of inherited photoreceptor 
degeneration and appears to act as a stress signal (99,100). RNA in situ hybridization revealed its 
primarily expression in photoreceptors cells (99). Immunohistochemical staining for EDN2 in our 
untreated wild-types showed a discrete immunolabeling at the ganglion cell layer (RGC) and in the 
retinal pigment epithelium (RPE), where the published in situ hybridization did not show any 
reactivity in untreated animals. In Rpe65-Norrin-2 animals, the immunolabeling was particularly 
strong in the ganglion cell layer with an additional intense staining of the photoreceptor inner 
segments and in the retinal pigment epithelium and a patchy immunostaining in the outer and inner 
plexiform layer (OPL/IPL). One possible explanation for the differences between the in situ 
hybridization and immunohistochemical staining is that the hybridization targets a specific transcript, 
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while immunohistochemical staining detects the protein's localization in the cell or tissue. The mRNA 
might be very low expressed in this cell type and/or the protein could have a very long half-life. 
 The higher amounts of EDN2 in Rpe65-Norrin-2 mice are most likely mediated by the induction of 
continuous Wnt/β-catenin signaling, since they are reduced to levels seen in wild-type retinae after 
treatment with DKK1. Moreover, blocking of EDN2 signaling with an EDNRB inhibitor (BQ788) 
diminished the protective effects of Norrin.  
One of the various functions of Müller glia cells is the secretion of neuroprotective factors (see 
1.1.1.4) (19). In the context of light damage it has been proposed that the release of LIF from Müller 
glia cells is the essential stimulus for the induction of EDN2 in photoreceptors, as experiments with 
Lif knockout mice (Lif-/-) did not show an upregulation of Edn2 in the context of photoreceptor 
degeneration (100).  
Since the constitutive increase in retinal Norrin levels did not result in a significant upregulation of Lif 
following light exposure, the Norrin-Wnt/β-catenin induced continuous higher expression of Edn2 
very likely does not require Müller cell-derived LIF. Our immunohistochemical staining indicated that 
EDNRB, the primary retinal receptor of EDN2, is mostly expressed in the inner segments of cone 
photoreceptors and additionally in the Müller cell end feet in Rpe65-Norrin-2 mice. Experiments with 
intravitreal BQ3020 injections, an endothelin receptor type B agonist, in wild-type mice showed that 
Endothelin signaling induces the synthesis of molecules that prevent or delay the degeneration of 
photoreceptors (100).  
As shown in the current thesis, the constitutively elevated EDN2 and EDNRB levels in Rpe65-Norrin-2 
mice might promote protective effects in a similar manner e.g. through Müller glia cells. The 
constitutive upregulation of GFAP, a marker for reactive Müller glia (19), and the localization of 
EDNRB on Müller glia end feet further support this hypothesis. Another indication for this is the 
significant lower neuroprotective effect of the Norrin Wnt/β-catenin/EDN2-signaling in the context of 
light exposure, when injecting the EDNRB inhibitor BQ788 several hours prior to light damage. 
3.1.4 Norrin neuroprotection and BDNF after light exposure 
Upon light exposure, Rpe65-Norrin-2 animals showed a significant mRNA upregulation of Bdnf and 
Ledgf. Both factors have neuroprotective effects (130–135). LEDGF was initially discovered in lens 
epithelial cells but is also expressed in neuronal tissues (136). BDNF is detected in the retinal ganglion 
cells, in Müller glia cells and cells of the inner nuclear layer (80,107,137).  
The expression of other neuroprotective factors released from Müller glia following light exposure 
such as Cntf and Fgf2 was not different in Rpe65-Norrin-2 mice than in wild-type littermates.  
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It is most likely that BDNF is the factor, which eventually mediates the neuroprotective effects of 
constitutively elevated Norrin-Wnt/β-catenin-EDN2-signaling and which is induced in Müller glia cells 
to rescue photoreceptors from light-induced damage. Experiments, with inhibition of either 
Wnt/β-catenin signaling (DKK1), or EDN2 signaling (BQ788) showed that retinal Bdnf expression relies 
upon these two pathways, strongly indicating that BDNF is a downstream target of these pathways. 
Immunohistochemical staining in wild-types showed no specific BDNF signal in their retinae 6 h after 
light exposure. In contrast Rpe65-Norrin-2 mice revealed a positive immunoreactivity for BDNF 
throughout the entire retina, which was especially intense on top of the retinal surface. Double 
labeling experiments with antibodies against either BDNF or GFAP (astrocytes, activated Müller glia), 
or BDNF and GS (Müller glia cells), indicated that the BDNF immunoreactivity in the innermost layer 
of the retina was localized to glia cells, which are most likely responsible for the initiation of further 
neuroprotective effects. 
It is of interest to note that the amounts of mRNA for Bdnf were diminished in light damaged 
wild-type retinae when compared to untreated wild-type animals, but Bdnf levels were significantly 
increased in light-damaged transgenic mice. It is tempting to speculate that the constitutive 
overexpression of Norrin in Rpe65–Norrin-2 mice does not only affect the transcription of Bdnf 
mRNA, but also its stability on protein level. To venture a guess, Norrin might interact with the 
proteasomal machinery which might explain a potential stabilization of BDNF following light 
exposure. The significant reduction of Smurf1, an ubiquitin ligase 3, in Rpe65-Norrin-2 animals 
supports this assumption. However, the Smurf1 downregulation is very likely the cellular response of 
the constitutively elevated Norrin levels in the retina, since Norrin inhibits BMP signaling by acting as 
an antagonist of BMP2 and 4 (89,90). Smurf1 ubiquitin ligase, together with inhibitory SMAD 6/7, 
forms a negative feedback loop for the attenuation of bone morphogenic proteins (BMP) signals by 
downregulating BMP-receptor and signaling molecules (140). Another observation heading in the 
same direction are the elevated β-catenin levels in Rpe65-Norrin-2 animals. β-catenin is 
ubiquitinylated through the E3-ubiquitin-ligase β-Trcp (β-transducin repeat containing) and then 
degraded by the proteasome. Therefore, the E3-ubiquitin-ligase β-Trcp might also be involved in this 
effect of Norrin. There are numerous ubiquitin ligases in a cell, so the downreguation of other E3 
ligases in these animals is very well possible, which might lead to a further stabilization of proteins 
like β-catenin and BDNF. 
After BDNF binding to its TrkB receptor (138), the receptor dimerizes and autophosphorylates the 
cytoplasmatic kinase domain. Briefly, this results in an activation of Ras, which then triggers PI3K, 
p38MAPK and c-Raf/ERK pathways (139). The phosphatidylinositol 3-kinase (PI3K) pathway leads to 
the activation of Akt through its phosphorylation. Activated Akt in turn phosphorylates and inhibits 
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pro-apoptotic Bcl-2 family members like BAD, BAX or Caspase-9. Following light exposure, 
Rpe65-Norrin-2 animals showed elevated levels of phosphorylated Akt, highlighting an activation of 
Akt signaling in the transgenic animals. The activation of Akt signaling, a major pathway mediating 
neuronal survival, following receptor-binding of BDNF (141) in retinae of Norrin overexpressing mice 
is consistent with the assumption that BDNF mediates the neuroprotective effects in transgenic 
animals. BDNF binds to TrkB receptor (138). In mouse photoreceptors, the TrkB receptor is not 
expressed. Its expression had been investigated in close detail using single cell RT-PCR (142), 
immunohistochemical staining (143,144), or by assessing TrkB promoter activity with reporter genes 
(145). Different results have been reported for immunohistochemical TrkB staining in the rat retina. 
In contrast to murine photoreceptors, rat green–red sensitive cones are immunoreactive for TrkB 
(146,147). Thus, it appears to be unlikely that BDNF directly influences photoreceptor survival in 
Rpe65-Norrin-2 animals via binding to its receptor TrkB. This strongly argues for an important role of 
the TrkB carrying Müller glia cells in mediating the protective effects of BDNF on photoreceptor 
survival. Observations that intravitreal injections of BDNF activate intracellular signaling pathways in 
Müller cells, further support this hypothesis (142,144). Either BDNF acts on Müller glia cells in an 
autocrine manner, or BDNF acts paracrine on certain retinal cell types, other than the 
photoreceptors, to induce the release of a so far unknown neuroprotective molecule that promotes 
photoreceptor survival. The deletion of TrkB in Müller glia inhibited the protective effects of BDNF on 
photoreceptor degeneration, which supports an autocrine mechanism (143). 
To sum up, the elevated BDNF levels are very likely involved in the photoreceptor protection 
following light exposure in Norrin overexpressing mice. Yet other, currently unknown signaling 
factors, which are for example released from Müller glia cells, might play a role, as well. 
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3.2 Norrin in the context of angiogenesis 
3.2.1 Vascular phenotype of Rpe65-Norrin-2 animals 
Norrin has angiogenic effects and is essential for retinal angiogenesis. The transgenic overexpression 
of Norrin in the lens (Nor-29) caused a persistence of the hyaloid vasculature and tunica vasculosa 
lentis during development (73).  
The hyaloid vessel system is a compact, temporary intraocular blood circulatory system (150). It 
undergoes progressive and nearly complete regression during the latest stage of ocular development 
when the lens, the vitreous and the retina mature (150). When the vasculature of Rpe65-Norrin-2 
mice was analyzed, we did not observe a persistence of the hyaloid vasculature or tunica vasculosa 
lentis. The difference to the Nor-29 animals can again be explained most likely through the different 
localization of the Norrin overexpression (lens versus retinal pigment epithelium) and the more 
moderate Norrin expression from the Rpe65 promoter in Rpe65-Norrin-2 animals. In addition, the 
immunohistochemical staining in Rpe65-Norrin-2 animals showed that the Norrin secretion reached 
only to the outer plexiform layer and thus may not reach the vitreous where the hyaloid artery is 
situated. The intraretinal vasculature in both animal models, Nor-29 and Rpe65-Norrin-2, is normal. 
The fact that Rpe65-Norrin-2 animals showed such a normal vascular morphology made them an 
even more promising model to investigate the influence of Norrin on angiogenesis, because the 
initial situation between transgenic and wild-type animals are absolutely comparable, suggesting that 
possible effects during the experiments are most likely due to Norrin and not due to a different 
vascular situation from the starting. 
The choriocapillaris is the adjacent vascular bed to the RPE, the cell population in which Norrin is 
overexpressed in the Rpe65-Norrin-2 animals. Therefore this is a comparable situation to the Norrin 
overexpression in the lens and its effect on the hyaloid artery and tunica vasculosa lentis. However, 
when the endothelium of the choriocapillaris was labeled with Plasmalemma vesicle-associated 
protein (PLVAP), a marker for fenestrated capillaries (151), no differences were detected between 
Rpe65-Norrin-2 mice and wild-type littermates. There are several possible explanations for this 
observation: first, in contrast to the hayloid vasculature the choriocapillaris does not degenerate 
during development, meaning that if Norrin has anti-degenerative effects on vascular cells, this effect 
will not be seen in an non-degenerative situation like the choriocapillaris. Second, the promoter 
activity of the RPE65 starts in late embryonic development and Norrin might therefore have other 
effects on choroidal vascular cells than on hyaloidal vascular cells that are under the influence of 
Norrin as early as E12.5. Third, it might be possible that Norrin is not secreted in the same manner in 
the direction of the choriocapillaris than it is secreted into the retina, a finding that is supported by 
our immunohistochemical staining. 
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3.2.2 Norrin in the ROP model 
To further validate the protective effects of Norrin in the context of angiogenesis, the model of 
retinopathy of prematurity (ROP) was used in the current thesis. This model is a well-established 
damage model (see 1.3.1) (152) that was used to induce vascular damage in transgenic Norrin 
overexpressing mice (βB1-Crystallin Norrin and Rpe65-Norrin-2) and wild-type littermates. Norrin 
overexpression protects mice from oxygen induced vaso-obliteration and this effect is mediated 
through the Wnt/β-catenin pathway. The influence upon vaso-obliteration was more pronounced in 
the βB1-Crystallin Norrin mice than it was in the Rpe65-Norrin-2 mice. These differences can be 
explained most likely due to the stronger expression of Norrin in the lens driven βB1-promoter 
compared to the moderate expressing from the Rpe65 promoter.  
Moreover, Norrin was able to induce the re-growth of retinal capillaries and the formation of the 
intra-retinal vasculature after oxygen mediated vascular damage. Again the effect was more 
prominent in the βB1-Norrin mice than in Rpe65-Norrin-2 mice. Again, most likely due to the 
stronger expression of Norrin in the lens driven βB1-promoter compared to the moderate expressing 
from the Rpe65 promoter.  
Additionally, Norrin prevented the development of preretinal tufts (neovascularization) (106). This 
reduction of neovascularization following ROP might be a consequence of the greater density of 
intravitreal vessels in a smaller eye (βB1-Norrin) and the Norrin induced increase in the number of 
intra-retinal capillaries. This in turn might lead to less hypoxia in the tissue and to a reduced 
expression of hypoxia induced angiogenic factors that stimulate neovascularization. But it is also 
possible that Norrin directly influences the direction of vessel growth. Experiments with  
Ndpy/-/Nor-29 mice support this hypothesis, since the ectopic Norrin expression restored normal 
intraretinal capillarization in Ndpy/- mice that normally lack intraretinal vasculature (73).  
In summary, Norrin is not only a protein that is primarily involved in the formation of the final 
capillary architecture in the retina but also reduced the ROP induced vaso-obliteration and prevented 
the formation of preretinal tufts. 
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3.3 Future directions 
It is worthwhile to mention, that overexpression of Norrin in the retinal pigment epithelium, 
concomitant with an activation of Wnt/β-catenin pathway in the retina and constitutive elevated 
retinal EDN2 levels did not result in any gross phenotypic changes. Neither Norrin, nor Frizzled4 
deficient mice show morphological changes of their photoreceptors, indicating that these factors are 
not essential for photoreceptor development, or their maintenance (71,73). Since photoreceptors 
express high amounts of Frizzled4 (129) and Norrin is continuously expressed even in adulthood (71), 
both molecules may be part of a neuroprotective pathway in the retina, although they are not 
required for photoreceptor maintenance. Taken together it is tempting to speculate that this 
pathway and Norrin could be used to delay or prevent inherited photoreceptor degeneration. 
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4 Summary – Zusammenfassung 
4.1 Summary 
Norrin is a secreted protein that binds to the frizzled-4 receptor to activate the canonical 
Wnt/β-catenin signaling pathway. Norrin is critical for normal vascular development in the retina. In 
addition, Norrin has neuroprotective properties. 
The aim of the current thesis was to investigate if Norrin has neuroprotective effects on 
photoreceptor survival following light exposure, if this neuroprotective effect is independent of its 
angiogenic component and which molecular mechanisms mediate its neuroprotective properties.  
To this end, transgenic mice were generated with a cell specific overexpression of Norrin in the 
retinal pigment epithelium (RPE). The overexpression led to a secretion of Norrin into the retina and 
subsequently the activation of the Wnt/β-catenin signaling pathway. The transgenic animals did not 
show obvious alterations in phenotype and retinal function. However, transgenic animals showed 
less photoreceptor vulnerability after light induced photoreceptor apoptosis. The neuroprotective 
effect of Norrin is most likely mediated through the Wnt/β-catenin signaling pathway, since 
intravitreal injections of the Wnt/β-catenin signaling inhibitor, Dickkopf1 (Dkk1) did reduce the 
neuroprotective effect significantly. Our data further indicate that endothelin2, which is expressed to 
a higher amount in transgenic animals, is involved in these neuroprotective effects, too. Intravitreal 
injections of an inhibitor for endothelin signaling (BQ788) did reduce the neuroprotective effect in 
the transgenic animals as well. Most likely, Wnt/β-catenin and endothelin2 influence the synthesis of 
brain derived neurotrophic factor (BDNF), whose mRNA expression was significantly reduced after 
intravitreal injections using both inhibitors either Dkk1 (Wnt/β-catenin pathway) or BQ788 
(Endothelin signaling). Furthermore, transgenic animals showed an activation of the Akt pathway 
(pAkt), a signaling pathway that is activated through BDNF. 
In conclusion, constitutive elevated Norrin levels in the retina protect photoreceptors from light 
damage, an effect that involves Wnt/β-catenin/EDN2-signaling and results in higher amounts of 
BDNF and pAkt in light damaged retinae, which might mediate the observed neuroprotective effects.  
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4.2 Zusammenfassung 
Norrin ist ein sezerniertes Signalprotein, das über eine Bindung an den Frizzled-4 Rezeptor den 
kanonischen Wnt/β-catenin Signalweg aktiviert. Während der Entwicklung ist Norrin essentiell für die 
Ausbildung eines intraretinalen Kapillargebiets in der Netzhaut. Weiterhin gibt es Hinweise für eine 
direkte neuroprotektive Wirkung von Norrin.  
Ziel der vorliegenden Doktorarbeit war es, zu untersuchen, ob Norrin Photorezeptoren vor einem 
experimentellen Schaden schützen kann, ob diese neuroprotektive Wirkung unabhängig von seiner 
angiogenen Wirkung ist und welche molekularen Mechanismen daran beteiligt sind.  
Dazu wurden transgene Mäuse generiert mit einer Zell-spezifischen Überexpression von Norrin im 
retinalen Pigmentepithel. Diese Überexpression führte zu einer Sekretion von Norrin in die Netzhaut 
und zu einer Aktivierung des kanonischen Wnt/β-catenin Signalwegs. Bei den trangenen Tieren 
fanden sich keine offensichtlichen Veränderungen in Struktur und Funktion der Netzhaut. Nach 
einem experimentellen Lichtschaden der Photorezeptoren zeigte sich bei den transgenen Tieren ein 
deutlicher Schutz der Photorezeptoren vor einem apoptotischen Zelltod nach Lichtschaden. Diese 
neuroprotektive Wirkung von Norrin wird wahrscheinlich durch den Wnt/β-catenin Signalweg 
vermittelt, da eine intravitreale Injektion mit dem Inhibitor des Wnt/β-catenin Signalwegs, Dickkopf1 
(Dkk1), den protektiven Effekt von Norrin aufhob. Weiterhin deuten unsere Daten darauf hin, dass 
auch Endothelin2, welches in der Netzhaut transgener Tiere in größeren Mengen nachweisbar war, 
an der neuroprotektiven Funktion von Norrin beteiligt ist. Die intravitreale Injektion des Endothelin2-
Inhibitors BQ788 führte ebenfalls zu einer Aufhebung des neuroprotektiven Effektes von Norrin. 
Vermutlich wirkt Wnt/β-catenin und Endothelin2 auf die Synthese von brain derived neurotrophic 
factor (BDNF), dessen mRNA Expression nach Gabe von Dkk1 oder BQ788 signifikant reduziert war. 
Weiterhin zeigten transgene Tiere eine Aktivierung des Akt Signalwegs (pAkt), der über brain derived 
neurotrophic factor aktiviert wird.  
Zusammenfassend kann gesagt werden, dass ein konstitutiv erhöhter Norrinspiegel in der Netzhaut 
Photorezeptoren vor einem Schaden schützt. An diesem neuroprotektiven Effekt sind der 
Wnt/β-catenin/Endothelin2- Signalweg beteiligt, welche eine Erhöhung von BDNF bedingen und zu 
einer Aktivierung des Akt Signalwegs (pAkt) führt. 
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5 Material and methods 
5.1 Methods 
5.1.1 Animal models.  
All procedures conformed to the tenets of the National Institutes of Health Guidelines on the Care 
and Use of Animals in Research, the EU Directive 2010/63/E, and the Uniform Requirements for 
manuscripts submitted to Biomedical journals. All mice were kept in cyclic light (12 h on/12 h off) 
with lights on at 7 am and a light intensity of approximately 400 lux. The mice had access to food and 
water ad libitum. 
5.1.1.1  Rpe65-Norrin-2 mice 
Rpe65-Norrin mice were generated as described previously (153). These mice express ectoptic Norrin 
in the retinal pigment epithelium (RPE) under the control of the RPE specific promoter RPE65 (116). 
The animals were bred on a mixed FVB/N × CD1 background (F1). They were albino and homozygous 
for the L450 variant of RPE65 (36). 
 
Figure 61: Schematic of the Rpe65-Norrin construct 
5.1.1.2 βB1-Crystallin Norrin mice 
Transgenic βB1-Crystallin Norrin mice were generated as described previously (73). These animals 
express ectoptic Norrin in the lens under the control of the lens specific βB1-crystallin promoter 
(114). The mice were bred in a FVB-N background. 
 
Figure 62: Schematic of the βB1-Crystallin Norrin construct 
5.1.1.3 Wnt-Reportermice: TOPGAL mice 
TOPGAL mice were purchased from Jackson Laboratories (http://jaxmice.jax.org, strain name: STOCK 
Tg(Fos-lacZ)34Efu/J). These mice express a β-galactosidase gene under the control of a Lef/Tcf and 
β-catenin inducible promoter (Figure 63) (154). After performing LacZ staining, the bluish colour of 
the LacZ stain indicates cells/tissues with an active Wnt/β-catenin pathway. 
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Figure 63: Schematic of the TOPGAL construct  
The promoter encloses three consensus Lef-1/Tcf binding motifs (L) followed by a minimal c-fos promoter to 
drive the transcription of the LacZ gene, which encodes for the β-galactosidase protein. Figure taken from 
(154). 
Some of the data of the current project are already published, hence the description of the following 
methods is partly published in (107,153).  
5.1.2 DNA analysis  
5.1.2.1 DNA isolation 
To obtain a tissue sample for the extraction of genomic DNA, the mice were anaesthetized with 
isoflurane and 0.3-0.5 cm of the mouse tail tip was cut. The tissue sample was transferred to a 1.5ml 
tube and 200 µl mouse tail lysis buffer (see buffer and diluaions) was added. Afterwards the samples 
were incubated at 55°C overnight in a thermomixer shaker at 600 rpm (rounds per minute). The next 
day, the proteinase K was inactivated by heating the lysate up to 95°C for 15 min. Then the samples 
were centrifuged at 14000 rpm for 10 minutes. 2 µl (concentration: approximately 30 ng/µl) of the 
supernatant was taken as DNA template for PCR analysis. 
5.1.2.2 Genotyping: Polymerase chain reaction (PCR) 
5.1.2.2.1 Genotyping for the transgenes: Norrin and LacZ 
This method was developed by K. Mullis and is used to a large extend in molecular biology to amplify certain 
DNA sequences (155). The PCR analysis in this project was used for the genotyping of the transgenic Rpe65-
Norrin, βB1-Crystallin Norrin and TOPGAL animals (Figure 64). The detailed protocols are shown in Table 1 
and primer sequences are given in  
 
 
Table 2. For all genotyping protocols mouse tail DNA was used as a template. 
Table 1: Standard PCR protocol and program for Rpe65-Norrin, β-B1-Norrin and TOPGAL genotyping 
10x PCR buffer 2.5 µl       temperature  duration       
MgCl2 (25 mM) 1.5 µl       94°C  2 min       
dNTPs (10 mM) 0.5 µl       94°C  30 s   │    
Primer F (10 µM) 0.5 µl       55°C (SV40)  30 s   │ 34x    
Primer R (10 µM) 0.5 µl       60°C (TOPGAL)  30 s   │    
Taq DNA polymerase 0.5 µl       72°C  1 min   │    
H2O 17 µl       72°C  5 min       
DNA template 2 µl       10°C   hold      
 
 
 
 
Table 2: Genotyping primer 
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Primername Mouseline Sequence Product size 
SV40-F 
SV40-R 
Norrin 
(RPE, βB1) 
5'-GTGAAGGAACCTTACTTCTGTGGTG-3' 
5'-GTCCTTGGGGTCTTCTACCTTTCTC-3' 
300 bp 
Rosa-LacZ -F 
Rosa-LacZ -R 
TOPGAL 5'-ATCCTCTGCATGGTC AGG TC-3' 
5'-CGTGGCCTGATTCATTCC-3' 
315 bp 
MwoI-F 
MwoI-R 
leu/met 
mutation 
5′- CACTGTGGTCTCTGCTATCTTC-3′ 
5′- GGTGCAGTTCCACTTCAGTT-3′ 
674bp 
 
 
Figure 64: Genotyping for transgene Rpe65-Norrin-2 animals 
Standard: 100bp, control = H2O control 
 
5.1.2.2.2 Genotyping for the leucine variant of Rpe65 
Since a point mutation at position 450 in the Rpe65 gene (resulting in a base exchange from 
methionine to leucine) has major influence on the susceptibility to light damage, all out animals were 
genotyped and bred for the leucine variant of this point mutation (35–38,156). 
Table 3: PCR protocol and PCR program for leucin/methionin genotyping of Rpe65 gene 
10x PCR buffer 5 µl       temperature  duration       
MgCl2 (25 mM) 3 µl       94°C  2 min       
dNTPs (10 mM) 2 µl       94°C  30 s   │    
Primer F (10 µM) 2 µl       55°C   45 s   │ 34x    
Primer R (10 µM) 2 µl       72°C  1 min   │    
Taq DNA polymerase 2 µl       72°C  5 min       
H2O 29 µl       10°C  hold       
DNA template 4 µl                
 
12µl of PCR product (see Table 3) was digested with 8 µl H2O and 0.3µl MwoI at 37°C for 3h. The 
leucine codon generates a restriction site for MwoI, which results after digestion in 2 DNA products 
of 437 bp and 236 bp (Figure 65). 
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Figure 65: Leucin/methionin PCR before (upper panel) and after (lower panel) MwoI digest 
Standard: 100bp, neg. co = negative control (H2O control) 
 
5.1.2.3 Agarose gel electrophoresis 
To visualize and analyse the amplified PCR products, gel electrophoresis was used. For the gel 1 g of 
agarose was dissolved in 100 ml TBE buffer and heated up in a microwave oven for 5 min. After 
letting the solution cool down, 3 µl of ethidium bromide was added. Ethidium bromide intercalates in 
the DNA and fluoresces when excited with UV light. Loading dye was added to the PCR product and 
the samples were loaded in the gel. The DNA products were separated through the electric field in 
the gel according to their molecular size. A standard with defined molecular size was added at the 
very left pocket of the gel. That allows the verification of the correct molecular size of the amplified 
PCR product. 
5.1.2.4 Southern blot analysis 
To perform southern blot analysis mouse tail and spleen DNA was isolated using the Bio-sell tissue 
DNA isolation kit. Subsequently 10 µg of the isolated mouse tail and spleen genomic DNA were 
digested with 20 U EcoRV (+ 1 µl BSA (1:10), 1 µl buffer 3) at 37°C overnight. After inactivating the 
enzyme with heating the samples up at 80°C for 20 min, DNA sample buffer was added and the 
samples were pipetted into a 1% agarose gel, supplemented with ethidium bromide, that run for 
2.5 h at 120 V. Afterwards the gel was washed under gentle shaking with the chemicals and durations 
as listed in Table 4.  
Table 4: Wash steps for southern blot analysis: day 1 (all steps: room temperature) 
20 minutes 250 mmol HCL depurination 
2x 15 minutes 0.5M NaOH + 1.5M NaCl denaturation 
2x 15 minutes 0.5M Tris-HCL + 1.5M NaCl neutralisation 
10 minutes 20x SSC equilibration 
 
Then gel was blotted via capillary blot overnight onto a nylon membrane. The next day the 
membrane was dried and crosslinked with an intensity of 1600 Joule with a Stratagene Crosslinker. 
Afterwards, the crosslinked membrane was pretreated with DIG easy Hyb for 30 minutes at 49°C 
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(prehybridisation). In the meanwhile the probe (concentration: 20 ng/µl) was prepared: 10 µl of the 
probe were diluted in 100 µl H2O heated up to 95°C for 5 minutes and then left on ice for 2 minutes. 
Then the probe was added to the membrane with fresh DIG easy Hyb for hybridisation at 49°C 
overnight. The next day, the membrane was washed as listed in Table 5 and finally detection of the 
membrane was performed in a LAS 3000 Intelligent Dark Box. 
Table 5: Wash steps and detection for southern blot analysis: day 2 
2x 5 minutes 2xSSC + 0.1% SDS  room temperature 
2x 15 minutes 0.1xSSC + 0.1% SDS  70°C 
2 minutes Wash buffer room temperature 
30 minutes Blocking: 1xDIG room temperature 
30 minutes 1xDIG + AP fragment (1:10000) room temperature 
3x 10 minutes Wash buffer room temperature 
5 minutes Detection buffer room temperature 
5 minutes Detection buffer + CDP star (1:100) room temperature 
X minutes Detection: LAS imager  
 
5.1.2.5 Southern and northern blot probe 
The generation of the Southern and northern respectively blot probe is described in (106) (see also 
Table 6). 
Table 6: Primer sequences for southern and northern blot probes 
name Sequence Product size: 
Norrin - F 5'- AGCTCAAAGATGGTGCTCCT-3′ 490 bp 
Norrin - R 5'- TAGAGCCAACAGGGGAAATG-3′   
 
5.1.3 RNA analysis 
RNA was isolated from dissected retinae. To obtain the retina, the mice were killed with cervical 
dislocation and the eyes were enucleated. The eye ball was carefully cut with a razor blade on top of 
the cornea without bruising the lens. The lens was removed as well as the anterior part of the globe 
and the retina was detached from the RPE and sclera with gentle brushes from the position of the 
optic nerve head. 
5.1.3.1 RNA isolation 
Following preparation, the retinae were put in a 2 ml Eppendorf tube on ice immediately and 250 µl 
TRIzol (Invitrogen) was added. TRIzol contains phenol and guanidine isothiocyanate and is broadly 
used for cell lysis, inactivation of RNAses and stabilisation of the RNA. Shortly after adding the TRIzol 
the samples were homogenized and further RNA isolation was performed as described in Table 7. 
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Remark: after adding chloroform (step 2 of the protocol in Table 7) and centrifugation the TRIzol 
lysate appears in 3 phases. The upper aqueous phase contains the RNA, the middle interphase 
contains precipitated proteins and the lower (organic) phase contains DNA, dissolved proteins and 
lipids. 
Table 7: RNA isolation protocol 
 5 minutes Incubate at room temperature Cell lysis 
  add chloroform (1/4 of the sample volume) to the lysed tissue, 
vortex 
Protein 
precipitation 
 20 minutes Incubate on ice  
 20 minutes Centrifuge at 14.000 rpm, 4°C Phase separation 
  Transfer the upper transparent aqueous phase to a new cup 
(1.5ml) 
 
  add isopropanol (1/1 of the sample volume) to the upper 
phase, vortex 
RNA precipitation 
 overnight Freeze at -20 °C  
 20 minutes Centrifuge at 14.000 rpm, 4°C  
  Remove supernatant  
  Add 500 µl 70% ethanol, vortex Wash step 
 5 minutes Centrifuge at 14.000 rpm, 4°C  
 1-2 
minutes 
Dry the pellet for approximately 2 minutes  
  Add 15 µl RNAse free water, store at -80°C RNA dissolving 
 
The integrity of the obtained RNA was checked on a 1% agarose gel prior to further experiments like 
cDNA synthesis or Northern blotting (Figure 66). 
 
Figure 66: Agarose gel electrophoresis to prove RNA quality 
Intact RNA sample exhibit a 2:1 ratio of 28S to 18S ribosomal RNA signal intensities. 
5.1.3.2 Complementary DNA (cDNA) synthesis  
cDNA is synthesized from a messenger RNA (mRNA) template using the enzyme reverse 
transcriptase. The enzyme reverse transcriptase operates on the single strand of mRNA and 
generates its complementary DNA. This process is based on the coupling of RNA base pairs (A, U, G 
and C) to their DNA counterparts (T, A, C and G). First-strand cDNA synthesis was performed using 
iScript cDNA Synthesis Kit (Bio-Rad) according to manufacturers’ instructions. Briefly, 1 µg of RNA in 
H20 was inserted into the reaction mix listed in Table 8 and cDNA amplification program was 
performed (Table 8). 
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Table 8: cDNA synthesis: reagents and amplification program 
reagents +RT -RT       temperature  duration 
iScript reverse transcriptase 1 µl -       25°C   5 min 
5x script 4 µl 4 µl       42°C  30 min 
1 µg RNA in H2O 15 µl 16 µl       85°C  5 min 
         4°C   hold 
 
5.1.3.3 Quantitative realtime RT-PCR  
Quantitative real-time RT-PCR analyses were performed with the reversed transcribed samples (+RT) 
using the Bio-Rad iQ5 Real-Time PCR Detection System. A H2O control and RNA that was not reverse 
transcribed (–RT) served as negative control for real-time RT-PCR. See Table 9 for mix and conditions. 
Table 9: Realtime RT-PCR: PCR protocol and program 
reagent volume temperature duration  
Sample ( +RT, -RT, H2O) 0.15 µl 95°C 15 minutes  
10x PCR buffer 1.5 µl 95°C 10 seconds │ 
MgCl2 (25 mM) 0.6 µl 60°C  40 seconds │ 40x 
dNTPs (25 mM) 0.12 µl 72°C 10 seconds │ 
Taq DNA polymerase (5 U/µl) 0.06 µl 95°C 1 minute  
SYBR-Green I (7.4% (v/v) in DMSO) 0.19 µl 55°C 1 minute  
Fluorescein 0.015 µl 55°C + 0,5°C per cycle  6 seconds 81 x 
H2O 12.03 µl (melt curve)   
Primer F (1 µM) 0.17 µl    
Primer R (1 µM) 0.17 µl    
 
5.1.3.4 Primer for real-time RT-PCR 
All oligonucleotides were purchased from Invitrogen (Table 10) and were intron spanning (except 
GAPDH). 
Table 10: Primer pairs for real-time RT-PCR (published in (107)). 
Product Sequence Position Tm [°C] Product size 
BDNF 5`- agtctccaggacagcaaagc -3` 
5`- tgcaaccgaagtatgaaataacc -3` 
614 – 633 
685 - 707 
59 
60 
94 
EDN-2 5`- acctcctccgaaagctgag -3` 
5`- tttcttgtcacctctggctgta -3` 
502–520 
556 –577 
59 
59 
76 
FGF2   5`- cggctctactgcaagaacg -3 ` 
5`- tgcttggagttgtagtttgacg -3` 
285 – 303 
371 - 392 
59  
60 
108 
GFAP 5`- acagactttctccaacctccag -3` 
5`- ccttctgacacggatttggt -3` 
1217 – 1238 
1260 – 1279 
59 
59 
63 
LEDGF 5`- ggccagcagtaagacaaagc -3` 
5`- tgaagctgccgacctagttat -3` 
1513 – 1532 
1584 – 1604 
60 
59 
92 
LIF 5`- aaacggcctgcatctaagg -3` 
5`- agcagcagtaagggcacaat -3` 
172–190 
245–264 
60 
59 
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CNTF  5`- ttgattccacaggcacaaaa-3` 
5`- ccctgcctgactcagaggt -3` 
42 – 61 
85 - 103 
60 
60 
62 
EDN-R-B 5`- cggtatgcagattgctttga -3` 
5`- aacagagagcaaacacgagga -3` 
1023 – 1042 
1094 – 1114 
59 
60 
92 
PEDGF 5`- ggactctgatctcaactgcaag- 3` 
5`- aagttctgggtcacggtcag- 3`  
795 – 816 
868 – 887 
59 
60 
93 
GAPDH 5`- tgtccgtcgtggatctgac -3` 
5`- cctgcttcaccaccttcttg -3` 
763–781 
818–837 
60 
60 
75 
 
To allow relative quantification GAPDH was used. Quantification was performed using BioRad iQ5 
Standard-Edition (Version 2.0.148.60623) software (BioRad). 
5.1.3.5 Northern Blot analysis 
For Northern blot analysis retinal RNA was isolated as described above. Northern blot sample buffer 
was added to 10 µg of each RNA sample, the mixture was heated to 65°C for 5 minutes and then 
quickly cooled down on ice for 2 minutes. Afterwards, the samples were loaded onto the northern 
blot agarose gel (see Table 11) and run at 100 V for 60 minutes. Then RNAs were transferred by 
capillary blot onto a positively charged nylon membrane and Norrin RNA was detected by forming a 
RNA/DNA hybrid with the probe. The Digoxigenin (DIG) labeled probe was prepared according to the 
manufacturer's manual and as described in detail in (153). Prior to hybridization the membrane was 
pre-incubated for 1 h at 60°C in hybridization buffer. Then the probe was added for hybridization and 
the blot was incubated with gentle turning in a hybridization oven at 60°C overnight to form the 
RNA/DNA hybrid. After hybridization the blot was washed 2x with hybridization buffer and two times 
with 0.1xSSC, 0.1%SDS at the used temperature. Subsequently, the membrane was shortly in DIG 
washing buffer (100 mM maleic acid, 150 mM NaCl, pH 7.5 and 0.3% N-lauroylsarcosin) and 
afterwards blocked for 1 hour with 1x blocking reagent (Roche) in 100 mM maleic acid, 150 mM 
NaCl, pH 7.5. Next, 0.75 U/ml of anti-DIG antibody conjugated to the alkaline phosphatase (Roche) in 
blocking buffer was added and incubated for further 45 minutes at RT. The membranes were washed 
three times in DIG washing buffer and incubated for 5 minutes in detection buffer (100 mM Tris pH 
9.5, 100 mM NaCl, 5 mM MgCl2). 1% CDP-star in detection buffer (Roche) was added and the 
chemiluminescence signals were detected with a Fuji LAS Reader 3000. 
Table 11: Northern blot gel (150ml) 
Agarose 1.50 g 
DEPC-H2O 109.5 ml 
10x MOPS 15 ml 
Formaldehyde 25.5 ml 
Ethidium bromide 3 µl 
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5.1.4 Protein analysis 
5.1.4.1 Protein isolation  
After TRIzol (Invitrogen) based RNA isolation the remaining lysates of neuronal retinae were treated 
following the manufacturer’s instructions for protein isolation. The detailed steps are listed in Table 
12. 
Table 12: Protocol for protein isolation 
Optional (DNA isolation): 
10 minutes incubation, 
room temperature 
Add 375 µl 100% ethanol to the interphase and phenol-chloroform 
phase of the previously performed TRIzol based RNA isolation (original 
TRIzol volume 250µl) 
15 minutes, 4°C Centrifuge at 12000 x g 
 Transfer the supernatant in a new reaction tube and discharge the 
former tube with the DNA pellet 
Protein isolation: 
10 minutes incubation, 
room temperature 
Add 375 µl 100% isopropanol to the supernatant 
10 minutes Centrifuge 12000 x g, discharge the supernatant 
3x 20 minutes wash 
buffer and  
3x 5 minutes 
centrifugation, 4°C 
Wash the precipitated protein pellet in 1 ml 0.3 M guanidine 
hydrochloride (in 95% ethanol) and 
centrifuge at 7600 x g 
20 minutes incubation Add 1 ml 95% ethanol, vortex 
5 minutes, 4°C Centrifuge 7600 x g, discharge the supernatant 
1 minute Dry the protein pellet 
overnight 50°C  
or  
 
65°C 15 minutes 
Dissolve the protein pellet  
either in 1% SDS + protease inhibitors (1:1000) and incubate at 50°C 
overnight 
or in urea buffer at 65°C, 15 minutes 
optional: 5 minutes, RT Centrifuge insoluble contains down and transfer the protein lysate in a 
new reaction tube 
-80°C storage 
 
5.1.4.2 Western blot analysis  
For Norrin Western Blots, the supernatant was separated by Urea-PAGE (4/3 16% Acrylamid + 6 M 
Urea). For other proteins, Proteins were separated by SDS-PAGE (10%, BDNF: 15% gel) and 
transferred to a polyvinyl difluoride membrane (Milipore), which was incubated with PBS containing 
0.1% Tween 20 (PBST; pH 7.2) and 3% bovine serum albumin or 5% non-fat dry milk overnight. 
Antibodies were used as described in Table 13. After washing with PBS-T, secondary antibodies 
(1:2000) were added. Chemiluminescence was detected on a BAS 3000 imager work station 
(Fujifilm). For normalization, blots were re-probed for glyceraldehyde 3-phosphate dehydrogenase 
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(GAPDH). Western blot signals were evaluated by relative densitometry with the Aida Image Analyzer 
v.4.06 software (Raytest). 
5.1.4.3 Antibodies and blocking solutions for Western blot analysis 
Table 13: Antibodies and blocking solutions for western blot analysis (published in (107)). 
Primary antibody Blocking Secondary antibody 
Norrin (R&D Systems) 1:1000 3% bovine serum albumin chicken anti-goat coupled to 
horseradish peroxidase (Millipore)  
-catenin (Cell Signaling) 
1:2000 
5% non-fat dry milk chicken anti-rabbit coupled to 
horseradish peroxidase (Santa Cruz 
Biotechnology) 
pAkt (Cell Signaling) 1:500 3% bovine serum albumin chicken anti-mouse coupled to 
alkaline phosphatase (Santa Cruz 
Biotechnology) 
Akt (Cell Signaling) 1:1000 5% non-fat dry milk goat anti-rabbit coupled to 
horseradish peroxidase (Rockland) 
Brain-derived neurotrophic 
factor (Alomone) 1:200 
3% bovine serum albumin goat anti-rabbit coupled to 
horseradish peroxidase (Rockland) 
Glyceraldehyde 2-phosphatase 
dehydrogenase (Abcam) 
1:10.000, HRP conjugated  
5% non-fat dry milk  
 
5.1.4.4 Apoptosis: cell death detection ELISA 
Apoptotic cell death was analysed by Cell Death Detection ELISA (Roche Diagnostics) which 
determines histone-associated DNA fragments (mono- and oligonucleosomes) in the cytoplasmatic 
fraction of cell lysates. To this end, the retinae of animals 30 h after 30 min light damage were 
investigated following manufacturers’ instructions. The methodical principle of this ELISA is shown in 
Figure 67. In brief, the ELISA plate was coated with streptavidin and incubated with an anti-histone-
biotin conjugated antibody. This led to the formation of a streptavidin-biotin complex. In general, the 
proteins avidin or streptavidin respectively are used to a broad extend in molecular biology or 
histology because of their potent binding ability of biotin. Avidin is found in chicken egg white while 
streptavidin is expressed in the bacteria Streptomyces avidinii (157). These two proteins have a 
molecular mass of approximately 60 -75 kDa and consist of 4 identical subunits which each can bind 
the vitamin biotin with very high affinity (158). That is why they are useful tools in molecular biology. 
In the cell death detection ELISA, the principle strepatividin-biotin method was used to detect the 
grade of light induced apoptosis. During apoptosis DNases cut the genomic DNA in the linker region 
(inter nucleosomal region) which results in an appearance of mono- and oligonucleosomes. 
Subsequently, the sample solution containing nucleosomes in the retinal lysates of light exposed and 
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non-light exposed transgene and wild-type animals was pipetted into the ELISA plate. During 
incubation the mono- and oligosomes in the retinal lysates bind to the anti-histone-biotin, which is 
already bound covalent to the streptavidin coated ELISA plate. After incubation an anti-DNA-
peroxidase solution was added, followed by ABTS substrate. This led to a colorimetric change in the 
wells containing the light damaged samples. They appeared in a dark green color. Then colorimetric 
analysis was performed using an ELISA reader (Sunrise-Basic) and maghellan software. 
 
Figure 67: Schematic of the methodical principle of the Cell death detection ELISA
plus
 
(picture taken from: https://cssportal.roche.com/LFR_PublicDocs/ras/11774425001_en_11.pdf, PDF, page 13) 
 
5.1.5 Histology 
5.1.5.1 Phenotype analysis 
For phenotype analysis, the eyes of untreated Rpe65–Norrin mice were investigated at postnatal day 
(P) 5, 10, 15, and 20, as well as at 6 weeks, 3 and 6 month of age. Eyes of light-exposed animals were 
analyzed 7 d and 14 d after light damage. Before enucleation, a mark was set at the superior limbus. 
The eyes were then fixed for 24 h in Ito's fixative (Karnovsky, 1965) and embedded in Epon (Serva). 
Semithin sections of 1.0 µm thickness were cut along the mid-horizontal (nasal-temporal) plane and 
stained by Richardson’s stain (159). Further analysis was performed by semithin section light 
microscopy and transmission electron microscopy according to protocols published previously (80). 
The detailed morphometric analysis procedure following light exposure is explained in: animal 
experiments – light damage – light damage and morphometric read out: the spider diagram. 
5.1.5.2 Immunohistochemistry 
Norrin, endothelin-2 (EDN2), endothelin-receptor type B (EDN2-RB), plasmalemma vesicle-associated 
protein (PLVAP) immunohistochemistry and staining with IsolectinB4 was performed on frozen 
sections (12 µm). Eyes were fixed for 4 h in Methyl Carnoy’s (10% glacial acetic acid, 60% methanol, 
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and 30% chloroform), transferred to 50% and 25% methanol 30 min each, washed in phosphate 
buffer (0.1 M, PhP), incubated in 10%, 20%, 30% sucrose/PBS overnight at 4°C and shock frozen in 
tissue mounting medium (DiaTec). For glial fibrillary acidic protein (GFAP) and BDNF, paraffin sections 
(6 µm) were used. Eyes were fixed for 4 h in 4% paraformaldehyde (PFA) and embedded in paraffin. 
Paraffin sections were deparaffinized and washed in water for 5 minutes. Then, sections were 
washed for 5 minutes in PhP, blocked with 2% BSA in 0.1M PhP for 45 minutes, and incubated with 
primary antibodies (Table 14) in 0.2 % BSA at 4°C overnight. After three washes in PhP (5 minutes 
each), secondary antibodies (Table 14) were applied for 1 h at room temperature. Lac-Z-staining was 
performed in mixed Rpe65-Norrin-2 mice/TOP-Gal mice (The Jackson Laboratory) as described 
previously (154). Paraffin sections (6.0 µm) were cut, placed on glass slides (SuperFrost/Plus; Menzel) 
and analyzed by light microscopy (Carl Zeiss). 
5.1.5.3 Antibodies for immunohistochemistry 
Table 14: Antibodies for immunohistochemistry (published in (107)). 
Primary antibody Fixation Secondary antibody 
Norrin (R&D Systems) 1:25 Methyl Carnoy's goat anti-rabbit IgG Alexa 488  
highly cross adsorbed (Invitrogen) 1:1000 
   
Endothelin-2 (Prestige) 1:50 Methyl Carnoy's goat anti-rabbit IgG Alexa 488  
highly cross adsorbed (Invitrogen) 1:1000 
Endothelin-Receptor Type B 
(Alomone Labs) 1:50 
Methyl Carnoy's goat anti-rabbit IgG Alexa 488  
highly cross adsorbed (Invitrogen) 1:1000 
Glial fibrillary acidic protein 
(Dako) 1:500 
4% paraformaldehyde 
 
goat anti-rabbit + Biotin 1:500 (Vector) 
Streptavidin Alexa 488 1:1000 (Molecular 
Probes) 
Brain-derived neurotrophic 
factor (Alomone Labs) 1:20 
4% paraformaldehyde 
 
goat anti-rabbit + Biotin 1:500 (Vector) 
Streptavidin Alexa 488 1:1000 (Molecular 
Probes) 
Biotinylated Griffonia 
(Bandeira) Simplicifolia 
LectinI IsolectinB4 (Vector) 
1:20 
Methyl Carnoy’s Streptavidin Alexa 555 (Invitrogen) 1:1000 
Plasmalemma vesicle-
associated protein (pan-ECA, 
Santa Cruz) 1:50 
Methyl Carnoy’s Donkey anti rat Cy3 (Jackson 
ImmunoResearch) 1:2000 
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5.1.5.4 Apoptosis: TUNEL analysis 
DNA fragmentation is a characteristic of apoptosis. Terminal deoxynucleotidyl transferase dUTP nick 
end labeling (TUNEL) is an established method to detect DNA fragments. Apoptotic cell death was 
analyzed by TUNEL labeling using the Apoptosis Detection System (DeadEnd Fluorometric TUNEL, 
Promega). To this end the retinae of animals 30 h after 30 min light damage were investigated 
following manufacturers’ instructions (Figure 68).  
 
Figure 68: Schematic of the methodical principle of the TUNEL assay 
The enzyme TdT incorporates Biotin or – as in the TUNEL assay used in this project- FITC coupled nucleotides in 
the fragmented DNA. If biotin is used, streptavidin –horseradish peroxidase and colorimetric substrates like 
diamanobenzidin (DAB) are added in a second step. (picture taken from: 
http://www.rndsystems.com/product_detail_objectname_tunel_assay_principle.aspx) 
For quantitative analysis, the number of TUNEL-positive nuclei in mid-horizontal sections throughout 
the entire retina were counted using KatiKati2 
(http://www.geocities.jp/gen_0715/softs/katikati/index2.html) cell counter and normalized to the 
area of the outer nuclear layer, which was determined with the Axiovision 4.8 program from Zeiss. 
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5.1.6 Animal experiments 
5.1.6.1 Oxygen-induced retinal damage: The retinopathia praematurorum (ROP) model 
To induce ROP, mice with their nursing mother were exposed to 75% oxygen for 5 d from postnatal 
day (P) 7 to P12 according to the described protocol (151) and as indicated in Figure 69. 
 
Figure 69: Schematic of the ROP model 
Mice were exposed to high oxygen (75%) from d 7 to d 12. The following return to room air lead to a relative 
hypoxia, resulting in vessel proliferation. Figure taken from (160). 
Mice were killed at P12, or returned to room air until P14, P16 or P17. The effects of Norrin on 
capillary re-growth into ROP induced vasobliterated areas, the formation of intraretinal vessels and 
the development of preretinal neovascular tufts were analysed using retinal whole mounts (for 
detailed whole mount method explanation, see below). To this end, light-micrographs of retinal 
whole mounts were taken at a 5x magnification for documentation of the superficial vascular plexus 
and of preretinal neovascular tufts, the deep capillary plexus were recorded at a 20x magnification 
using the Apotome mode of an Axiovision fluorescent microscope (Carl Zeiss). The total area of the 
retina, the areas of preretinal neovascular tufts, of vasobliteration, and of the deep capillary plexus 
were measured and calculated as area of neovascular tufts per 1000 μm2 retina, area of 
vasobliteration per total retinal area as well as retinal area that was covered by deep plexus per total 
retinal area using the Axiovision software 4.8. To analyze the deep capillary plexus in cross sections 
retinal whole mounts were embedded in Tissue Tek and subjected to cryosectioning. 
5.1.6.2 Light damage 
Rpe65-Norrin mice, 6−9 week old, were transferred to cyclic dim light (<100 lux) for 5 days followed 
by a dark-adaption period of 12 h. Mice with dilated pupils (one drop Mydriaticum Stulln/eye) were 
then placed in reflective cages and exposed to diffuse cool, white fluorescent light coming from the 
top of the cage with an intensity of 5000 lux for 30 min (detection of apoptosis) or 1 h (other 
experiments). Average intensity was measured on the cage floor (5000 lux). After light exposure, 
mice were allowed to recover first for 6 h in dim light, and then sacrificed (mRNA analysis) or brought 
back to normal cyclic light conditions. Light damage experiments were always performed in the early 
morning. 
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5.1.6.3 Light damage and morphometric read out: the spider diagram 
Morphometric measurements were used to quantify the occurrence of the light damage per 
experimental group (wild-type versus Rpe65-Norrin-2). To this end, Richardson stained sagittal 
section from the nasal to temporal side through the optic nerve head were used. 
 
Figure 70: Morphometric analysis following light exposure 
A. schematic drawing of the measure points of the experimental eye. B. Example of a spider diagram of light 
exposed animals, showing the thickness of the outer nuclear layer throughout the retina at 21 measure points. 
C. Richardson stained semithin section of a control (no light) and a light exposed (light) animal to show the 
measure technique on the section. Figure taken from a manuscript in preparation: Barbara M. Braunger, 
Daniela Kawall and Ernst R. Tamm: Light-induced photoreceptor damage. 
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The length of the hemispheres of these sections was measured; the total length divided through 10 
and the thickness of the outer nuclear layer was measured between each 10th of the hemisphere. 
The means of the measure points were blotted in a so called spider diagram and statistical analysis 
was performed to compare single measure points throughout the entire retina between wild-type 
and Rpe65-Norrin-2 animals (Figure 70). 
5.1.6.4 Intravitreal injections 
In the ROP model, some of the animals were injected with 3 μl of Dickkopf-1 (DKK-1) [10 ng/μl] once 
into the vitreous of anesthetized mice after hyperoxia at P12. For light damage experiments and 
morphometry, DKK1 (R&D Systems) was injected 3 times (12 h before, and 2 and 4 d after light 
damage). Mice were anesthetized using isofluran (Baxter) and 3 µl DKK1 (10 ng/µl) or PBS 
(contralateral eye) were injected through the basal limbus using a 33 gauge needle. Animals were 
killed 7 days after light damage. For analysis of β-catenin or neuroprotective molecules, DKK1 or PBS 
were injected twice (15 and 3 h before light damage, or enucleation of the eyes in non-light damaged 
animals). BQ788 (1 µg/µl diluted in 5% DMSO in PBS) or 5% DMSO (contralateral eye), 2 µl each, 
were injected twice (15 and 3 h before light damage). Light-damaged animals were killed 6 h after 
light exposure. 
5.1.6.5 Fundus imaging and angiography 
Fundus imaging and angiography were performed in cooperation with Prof. Jägle, Regensburg. 
Retinal imaging was performed with a commercially available imaging system (Micron III; Phoenix 
Research Laboratories, Inc.). Light source path and imaging path filters (low pass and high pass at 500 
nm) were used for fluorescein angiography (FLA). Mice were anesthetized by s.c. injection of 
ketamine (65 mg/kg) and xylazine (13 mg/kg), and their pupils were dilated with tropicamide 
eyedrops (Mydriaticum Stulln; Pharma Stulln) before image acquisition. FLA was performed using a 
s.c. injection of 75 mg/kg body weight fluorescein-Na (Alcon). 
Laser scanning ophthalmoscopy (SLO) and optic cohaerence tomography (OCT) were performed in 
cooperation with Prof. Seeliger, Tübingen. Mice were anesthetized with ketamine (66.7 mg/kg b.w.) 
and xylazine (11.7 mg/kg b.w.), and the pupils were dilated with tropicamide eye drops prior to 
examination. 
5.1.6.6 Retinal whole mounts 
To analyze the vascular phenotype of 6-week-old Rpe65-Norrin mice, mice were deeply anesthetized 
with ketamine (120 mg/kg body weight, i.m.) and xylazine (8 mg/kg body weight) and perfused 
through the left ventricle with 1 ml of phosphate buffered saline (PBS) containing 50 mg high 
molecular weight (MW = 2,000,000) FITC-dextran (Sigma). The eyes were enucleated and placed in 
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4% paraformaldehyde for 4 hrs. Retinae were dissected and flat mounted using fluorescent mounting 
medium (Dako). Lightmicrographs of retinal whole mounts were taken at a 5x magnification to 
achieve an overview of retinal vasculature by using an Axiovision fluorescent microscope (Carl Zeiss). 
Retinal whole mount preparation and analysis was performed with the help of Dr. Andreas Ohlmann, 
Regensburg. 
5.1.6.7 Functional analysis: electroretinography (ERG) 
The functional ERG analyses were performed in cooperation with Prof. Matthias Seeliger, Tübingen. 
Electroretinographies were recorded binocularly in untreated animals and light exposed mice 2 
weeks after damage as described previously (161). Briefly, after overnight dark adaptation, mice 
were anesthetized with ketamine (66.7 mg/kg b.w.) and xylazine (11.7 mg/kg b.w.), and the pupils 
were dilated with tropicamide eye drops. Single-flash responses were obtained under dark-adapted 
(scotopic) and light-adapted (photopic) conditions. Light adaptation was achieved with a background 
illumination of 30 cd/m2 starting 10 min before photopic recordings. Single white-flash stimuli 
ranged from –4 to 1.5 log cd*s/m2 under scotopic and from –2 to 1.5 log cd*s/m2 under photopic 
conditions, divided into ten and eight steps, respectively. Ten responses were averaged with 
interstimulus interval of 5 or 17 s (for 0 to 1.5 log cd*s/m2). 
5.1.6.8 Rhodopsin recovery in darkness 
To determine the absolute rhodopsin content mice were dark adapted for 16 hours and all following 
procedures were performed under dim red light. Detailed steps are described in Table 15. To further 
analyze the ability of rhodopsin recovery in darkness which allows deeper conclusions of the proper 
function of the visual cycle, exactly the same analysis was performed as described in Table 15, except 
that the animals were exposed to 5000 lux for 10 minutes and either killed directly after the light 
exposure or after a following recovery period (10 min, 3h, 6h) in darkness. In general, all the steps of 
this protocol were performed according to the descriptions in (36,162). 
Table 15: Protocol for absolute rhodopsin content and rhodopsin recovery in darkness 
 Add both retinae to 1 ml H2O 
3 minutes, room temperature Centrifugation, 15000 x g 
 Discharge the supernatant and re-suspend the retinal pellet 
in 700 µl of 1% CTAB solution 
 Homogenize the retinae 
3 minutes, room temperature Centrifugation, 15000 x g 
 Measure the absorption of the supernatant at 500nm 
(plastic cuvette: 1 cm length) 
90 seconds, cool white light Expose the sample at 16000 lux to bleach all present 
rhodopsin and repeat the photometer measurement at 
500nm 
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Then the amount of rhodopsin present per retina was calculated. Therefore a formula derived from 
the Lambert–Beer equation and as described in (162) was used: 
rho = vol x c = vol x [Δabs500/(e x l x n)]  
rho: amount of rhodopsin per retina (in moles)  
vol: sample volume (in liters) 
c: rhodopsin concentration per retina (in mol/liters) 
Δabs500: difference between absorption before and after bleaching measured at 500 nm 
e: extinction coefficient of rhodopsin at 500 nm (4.2 × 104 cm × M) 
l: path length of the plastic cuvette (in centimeters) 
n number of retinae 
 
5.1.7 Statistical analysis 
Statistical differences between individual test populations were analysed by Student's t-test 
(heteroscedastic, two-tailed) using Ecxel software. P values < 0.05 were considered to be statistically 
significant. All results are expressed as mean ± SEM. 
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5.2 Material 
5.2.1 Chemicals and reagents 
10x PCR-buffer Qiagen, Hilden 
2-mercaptoethanol Roth, Karlsruhe 
Acetic acid, glazial Merck, Darmstadt 
Albumin fraction V (BSA) Roth, Karlsruhe 
Ammoniumperoxidisulfat (APS), 10% (w/v) Roth, Karlsruhe 
BC Assay reagent A+B Interchim, Wörgl, AUS 
Bromphenolblue Sigma-Aldrich, Taufkirchen 
BQ788 Sigma-Aldrich, Taufkirchen 
CDP star Roche, Mannheim 
Chloroform Roth, Karlsruhe 
Coomassie Brillant Blue R-250 Sigma-Aldrich, Taufkirchen 
CTAB: hexadecyltrimethyl-ammoniumbromide Fluka Chemie, Buchs, Switzerland 
DAPI: see Vectashield Linaris 
Deoxycholacid Roth, Karlsruhe 
DEPC (Diethylpyrocarbonat) Roth, Karlsruhe 
Diethylether Roth, Karlsruhe 
Dig Easy Hyb Roche, Mannheim 
di-Natriumhydrogenphosphat-Dihydrat Merck, Darmstadt 
Dkk-1 R&D Systems 
DMSO Roth, Karlsruhe 
dNTPs Qiagen, Hilden 
Dodecylsulfat (Na2-salt) Serva Electrophoresis GmbH, Heidelberg 
Dry milk  Roth, Karlsruhe 
Ethanol, absolute Roth, Karlsruhe 
Ethidium bromide Serva, Heidelberg 
FBS  Invitrogen, Karlsruhe 
FITC-Dextrane (MW: 200000) Sigma-Aldrich, Taufkirchen 
Fluoresceine Qiagen, Hilden 
Flouresceinisothiocyanat (FITC) Dextran Sigma-Aldrich, Taufkirchen 
Fluorescent Mounting Medium DakoCytomation, Hamburg 
Formaldehyde Roth, Karlsruhe 
Formamide Sigma-Aldrich, Taufkirchen 
Guanidin-HCL Roth, Karlsruhe 
Glycerine Roth, Karlsruhe 
Glycine Merck, Darmstadt 
Hycdrochloric acid 37 % (HCl) Merck, Darmstadt 
Immobilon Western HRP substrate Millipore Corporation, Billerica, USA 
Isoflurane Baxter, Unterschleißheim 
Isopropanol Roth, Karlsruhe 
Kaliumchloride Roth, Karlsruhe 
Kaliumdihydrogenphosphat Roth, Karlsruhe 
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Ketamin WDT, Garbsen 
Linde Gas (75% oxygen) Linde Gas GmbH 
Magnesiumchloride (25 mM) Qiagen, Hilden 
Maleic acid Roth, Karlsruhe 
Methanol Merck, Darmstadt 
MOPS Roth, Karlsruhe 
Mydriaticum Stulln (Tropicamide) eye drops Pharma Stulln Gmbh 
Na2HPO4 x H2O Roth, Karlsruhe 
Natriumchloride Roth, Karlsruhe 
Natriumhydrogenphosphat-monohydrate Merck, Darmstadt 
Nonidet P-40 = Tergitol Sigma-Aldrich, Taufkirchen 
Osmiumtetroxide Merck, Darmstadt 
Paraformaldehyd (PFA) Sigma-Aldrich, Taufkirchen 
PBS  Invitrogen, Karlsruhe 
Protease-inhibition-Mix M Serva Electrophoresis GmbH, Heidelberg 
Rotiphorese Gel 30 (30 % acrylamide-stock 
solution with 0,8 % bisacrylamid proportional 
37,5:1) 
Roth, Karlsruhe 
SYBR-Green Qiagen, Hilden 
Urea Sigma-Aldrich, Taufkirchen 
TEMED Roth, Karlsruhe 
Tergitol Sigma-Aldrich, Taufkirchen 
Tissue-Tek  Sakura, Zoeterwoude, NL 
Tris Ultrapure, MB Grade Usb Corporation, Cleveland, USA 
Tris Roth, Karlsruhe 
TRIzol-Reagenz Invitrogen, Karlsruhe 
Trypan blue solution (0,08 %) Sigma-Aldrich, Taufkirchen 
Tween 20 Roth, Karlsruhe 
Vectashield Mounting Medium for Fluorescence 
with DAPI 
Vector Laboratories, Burlingame, USA 
Water Rotisolv (Rnase-frei) Roth, Karlsruhe 
Xylazine Serumwerk Bernburg, Bernburg 
 
5.2.1.1 Enzymes and Taq polymerase 
Restriction endonucleases New England Biolabs 
Taq Polymerase New England Biolabs 
BioThermRed Taq DNA Polymerase NatuTec, Frankfurt 
Proteinase K Roth, Karlsruhe 
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5.2.1.2 Kits 
Cell death detection ELISA Roche, Mannheim 
DeadEndTM Fluorometric TUNEL System Promega, Madison, Wisconsin, USA 
iScript cDNA Synthesis Kit BioRad Laboratories, München, Deutschland 
HotStarTaq®DNA Polymerase 
Nexttec mouse tail kit 
Qiagen, Valencia, CA 
Bio-sell, Nürnberg 
 
5.2.2 Consumable supplies and equipment 
5.2.2.1 Consumable supplies 
Conical tubes 15 ml, 50 ml Sarstedt, Nürnbrecht 
3 MM blotting papers Neolab, Heidelberg 
Biosphere filter tips Sarstedt, Nürnbrecht 
Ear clips Hauptner & Herebrholz, Solingen 
Epon Serva, Heidelberg 
Cover slides, 24 x 60 mm Menzel-Gläser, Braunschweig 
Dispomed single use syringe Dispomed Witt oHG, Geinhausen 
Ecoflo perfusion set Dispomed Witt oHG, Geinhausen 
Laboratory glass Schott, Roth, VWR 
Liquid blocker PAP-Pen SCI Science Services, München 
Microseal „B“ Film Biorad, München 
Multi-reaction tubes 0,5 ml; 1,5 ml; 2,0 ml Roth, Karlsruhe 
Omnifix sterile single use syringes B. Braun, Wertheim 
Parafilm Pechiney Plastic Packaging, Chicago, USA 
Pasteurpipettes Brand, Wertheim 
PCR Plates, 96 well iCycler IQ Biorad, München 
Personna razor blades American Safety Razor Company, Verona, USA 
Pipet tips Sarstedt, Nürnbrecht 
Nitrile glooves VWR, Darmstadt 
Nylone membrane Roche, Mannheim 
PVDF-western blotting membrane Roche, Mannheim 
Serological pipettes Sarstedt, Nürnbrecht 
Sterican single use-injection needle B. Braun, Wertheim 
SuperFrost®Plus glas slide  Menzel-Gläser, Braunschweig 
 
5.2.2.2 Equipment 
Axiovert 40 CFL Zeiss, Göttingen 
BioPhotometer Eppendorf, Hamburg 
Electrophoresis power supply E835 Biorad, Hercules, USA 
Electron microscope 10A Zeiss, Göttingen 
Gel chamber for electrophoresis Peqlab Biotechnologie GmbH, Erlangen 
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Inolab pH-meter WTW GmbH, Weilheim 
IQ5 Multicolor Real-time PCR Detection System + 
iCycler 
BioRad, München 
Julabo SW20 waterbath Julabo Labortechnik GmbH, Seelbach 
Kern PJL 2100-2M balance Kern & Sohn GmbH, Balingen-Frommern 
LAS 3000 Intelligent Dark Box Fujifilm, Düsseldorf 
Mastercycler gradient, personal Eppendorf, Hamburg 
Memmert waterbath Memmert GmbH, Schwabach 
Mettler AE 163 special accuracy weighting 
machine 
Mettler Toledo, Gießen 
Microm HM 500 OM cryostats  Microm International, Walldorf 
Microscope Axio Imager Z1 Zeiss, Göttingen 
MilliQ Plus PF water destill machine Millipore Corporation, Billerica, USA 
Model 45-101-i class II electrophoresis system Peqlab Biotechnologie GmbH, Erlangen 
Pipetman Pipetten Gilson, Middleton, USA 
Polymax 1040 shaker Heidolph, Kelheim 
Research Pipets Eppendorf, Hamburg 
Semi-dry electrophoretic transfer cell Peqlab Biotechnologie GmbH, Erlangen 
Sunrise-Basic ELISA-Reader Tecan Austria GmbH, Grodig, AUS 
Systec V75 autoclave Systec GmbH, Wettenburg 
Thermomixer comfort Eppendorf, Hamburg 
Vortex Genie 2 Scientific Industries Inc., New York, USA 
Ultrospec 3100pro spectrophotometer  Amersham, GE healthcare, USA 
Centrifuge 5415D, 5415R, 5804R, 5810R Eppendorf, Hamburg 
Stratagene Crosslinker Herolab, Wiesloch 
HB-1000 Hybridizer UVP Laboratory Products, Cambridge, UK 
Ultracut microtome Reichert-Jung, Kirchseeon 
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5.2.3 Gels, buffers, dilutions 
5.2.3.1 Buffers and dilutions 
5.2.3.1.1 Histology 
EM-fixation 10 ml paraformaldehyde 25 % 
50 ml 0,2 M cacodylate buffer pH 7,6 
30 ml H2O 
Lac-Z-fixation 48.4 ml 0.1 M phosphate buffer pH 7.3 
100 µl 1 M MgCl2  
1.0 ml 0,250 M EGTA pH 7.3 
0.4 ml 25 % glutaraldehyde 
Lac-Z-staining 72.0 ml Lac-Z wash-buffer 
3.0 ml X-Gal (25 mg/ml in DMSO) 
0.159 g K4Fe(CN)63H2O 
0.123 g K3Fe(CN)6 
Lac-Z-wash-buffer 1 ml 1 M MgCl2 
5.0 ml 1 % NaDC 
5.0 ml 2 % tergitol 
489 ml 0.1 M NaPO4-buffer 
0,1 M phosphate buffer, pH 7.4 
 
Buffer 1: 0,1 M Na2HPO4 x 2 H2O 
Buffer 2: 0.1M NaH2PO4 x 1 H2O 
Buffer 1: buffer 2 (see table rows below) 
5:1, pH 7.4 
35.6g in 2l H2O 
13.8g in 1l H2O 
Natriumcacodylate buffer 0,1 M natriumcacodylate buffer 
0.1 M HCl, pH 7,4 
Osmiumferrocyanide 1 % osmiumtetroxide 
0,8 % kaliumhexacyanoferrat (II) 
Richardson stain Stock 1: 5 g (1 %) azur in 500 ml aqua dest. 
Stock 2: 5g in 500 ml 1% methylenblue in 1 % 
Natriumtetraborat solution  
Mix stocks: 1:1 ad 2 vol. H2O 
PFA-solution (4 %) Paraformaldehyde 4 %  
0,1 M phosphate buffer pH 7,4 
 
5.2.3.1.2 Protein analysis 
10x elektrode buffer 250 mM Tris/HCl  
400 mM Glycin  
1 % (w/v) SDS solve in H2O; ad 1 l 
Coomassie-destain 500 ml methanol  
10 ml acetic acid  
Ad H2O to 1 l 
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Coomassie-stain 40 ml Methanol  
2 ml acetic acid 
0,2 g Coomassie-Brilliant Blue R-250  
Ad H2O to 100 ml 
0,9 % NaCl 0,9 % (w/v) in dH2O, autoclave 
PBS, 10x, pH 7,4 80 g Natriumchloride  
2 g Kaliumchloride 
4,4 g Na2HPO4  
2,4 g KH2PO4  
ad dH2O to 1 l, autoclave 
Urea-buffer 25 ml 10 % SDS 
10 ml 1 M TRIS pH 6,8 
100 µl 0,5 M EDTA pH 8 
750 µl β-mercaptoethanol 
24 g urea 
SDS-solution, 10 % (w/v) 10 g SDS  
Solve in dH2O; ad 100 ml 
SDS-PAGE-buffer, 10x  250 mM Tris/HCl  
400 mM glycine  
1 % (w/v) SDS  
Solve in H2O; ad 1 l 
SDS-sample buffer, 4x 0,25M Tris/HCl, pH 6,8  
30 % glycerin  
8 % (w/v) SDS  
0,02 % (w/v) bromphenolblue  
0,3 M DTT bzw. 10 % β-mercaptoethanol 
TBS, 10x, pH 7,4 30 g Tris  
80 g Natriumchlorid  
2 g Kaliumchlorid  
Solve in H2O ad 1 l, autoclave 
TBST, 1x 100 ml 10x TBS  
0,05 % (v/v) tween 20  
Solve in H2O ad 1 l 
Transfer buffer, 10x 5,8 g tris  
2,9 g glycin  
200 ml methanol  
3,7 ml 10 % (w/v) SDS  
Solve in H2O ad 1 l 
Tris/HCl, 1,0 M, pH 6,8 121,14 g Tris  
Solve in H2O ad 1 l 
Tris/HCl, 1,5 M, pH 8,8 181,71 g Tris  
Solve in H2O ad 1 l 
Wash buffer for protein isolation 0,3 M Guanidin HCL  
Solve in 95 % Ethanol  
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Detection buffer, pH 9 0,1 M Tris-HCl 
0,1 M NaCl 
Urea-page: collection gel 
4/3 4% acrylamide + 6M urea 
17.7 ml Rotiphorese Gel30 
36.03g urea 
Ad 100 ml H20 
Urea-page: separation gel 
4/3 16% acrylamide + 6M urea 
71.1 ml Rotiphorese Gel30 
36.03g urea 
Ad 100 ml H20 
4x lower tris 1.5M Tris-Cl pH=8.8 
0.4% SDS 
4x upper tris 0.5M Tris-Cl pH=6.8 
0.4% SDS 
 
5.2.3.1.3 DNA analysis 
Mouse tail lysis buffer 50 mM KCl 
10 mM Tris-HCl, pH 8.3 
2 mM MgCl2 
0.1 mg/ml gelatine 
0.45 % Nonidet P-40 
0.45 % Tween 20 
Ad proteinase K before use 20 mg/ml 
DNA loading dye Bromphenol blue 0.25% (w/v) 
Xylene cyanol FF 0.25% (w/v) 
Ficoll 15% (w/v) 
10x TBE buffer TRIS 108g 
Borate 55g 
EDTA (0.5M), pH8 40ml 
Ad H2O (destilled) ad 1l 
Southern blot wash buffer, pH 7,5 100 mM maleic acid 
150 mM NaCl  
0.3 % Tween-20 
Southern blot blocking, pH 7,5 
1x DIG 
 
100 mM maleic acid 
150 mM NaCl 
1 % blocking reagent, Roche Mannheim, 
Germany 
5.2.3.1.4 RNA analysis  
Northern blot sample buffer 110µl DEPC-H2O 
50µml 10x MOPS 
90µl formaldehyde 
250µl formamide 
Northern blot buffer (for electrophoresis) 70ml 10xMOPS 
630ml H2O 
3,85ml formaldehyde 
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10x MOPS 41.9g MOPS 
4.1g Natriumacetate 
4.45g Natrium2acetate 
Sterile filtration, store in dark bottle 
5.2.3.1.5 Animal experiments 
1% CTAB 1g CTAB solve in 100ml H2O 
Dkk-1 Concentration: 10 ng/µl, injection volume: 
3µl/eye 
Dilute stock solution (100ng/µl in PBS) 1:10 in 
PBS 
BQ788 Concentration: 1µg/µl, injection volume: 
2µl/eye Dilute stock solution (20µg/µl in 
100%DMSO) 1:20 in PBS  
  
5.2.3.2 Polyacrylamide gel electrophoresis  
 
Table 16: SDS gels for western blot analysis 
 Stacking gel Resolving gel 10 % Resolving gel 15 % 
H2O 0,68 ml 1,9 ml 1,3 ml 
Rotiphorese® Gel 30 0,17 ml 1,7 ml 2,3 ml 
Tris/HCl, 1 M, pH 6,8 0,13 ml - - 
Tris/HCl, 1,5 M, pH 8,8 - 1,3 ml 1,3 ml 
10 % SDS 0,01 ml 0,05 ml 0,05 ml 
10 % APS 0,01 ml 0,05 ml 0,05 ml 
TEMED 0,001 ml 0,002 ml 0,002 ml 
 
Table 17: Gels for Urea page 
 Collection gel Separation gel 
4/3 4% acrylamide + 6 M Urea 750 µl - 
4/3 16% acrylamide + 6 M Urea - 3,75 ml 
4x lower Tris - 1,25 ml 
4x upper Tris 250µl - 
APS (25%) 10 µl 50 µl 
Temed 1 µl 5 µl 
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7 Abbreviations 
A    ampere   
α    alpha/ anti 
AMD    age related macular degeneration 
AU    arbitrary unit 
β    beta 
BDNF    brain derived neurotrophic factor 
bidest.    bidestillatus 
BMP     bone morphogenetic protein 
bp     base pair  
BrdU     bromdesoxyuridine 
BSA     bovin serum albumin 
°C    grade Celsius 
cDNA     complementary DNA  
cGMP    cyclic guanosine monophosphate  
CNS    central nervous system 
CNTF    ciliary neurotrophic factor 
d     day 
da     Dalton 
DAPI     4′,6-Diamidin-2-phenylindol 
DNA    deoxyribonucleic acid 
dNTPs     desoxyribonucleoside triphosphate 
dUTP    desoxyuridine triphosphate 
EDN2    Endothelin2 
EDNRB    Endothelin receptor type B 
ERG    electroretinography 
FGF-2    fibroblast growth factor 2 
FITC     fluorescein isothiocyanate-dextran  
fwd     forward 
g    gram 
GAPDH    glycerinaldehyd-3-phosphat-Dehydrogenase 
GFAP     glial fibrillary acidic protein 
GFP     green fluorescent protein 
GS    glutamine synthetase 
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h     hour 
H2O    water 
HRP    horseradish peroxidase    
k     kilo 
l     liter 
LEDGF    lens epithelium derived growth factor 
LIF    leukemia inhibitory factor 
M    Molar 
m    meter, milli   
MgCl2     magnesium chloride 
min    minute 
mm     mus musculus 
mRNA    messenger RNA  
MW    molecular weight 
µ     mikro  
n    nano  
NaCl    sodium chloride 
NDP    Norrin disease pseudoglioma 
Nor-29    βB1-Crystallin Norrin line 29 
P     postnatal day 
PBS     phosphate buffered saline  
PDE    phosphodiesterase 
PCR     polymerase chain reaction 
PEDF    pigment epithelium derived growth factor 
PFA     paraformaldehyd 
PLVAP    plasmalemma vesicle-associated protein 
PVDF     polyvinylfluoride 
rev    reverse 
RNA    ribonucleic acid 
RPE    retinal pigment epithelium 
rpm     revolutions per minute 
rTdT     terminal deoxynucleotidyl transferase, recombinant 
RT    room temperature  
ROP    retinopathia of prematurity 
s    second 
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SEM    standard error of the mean 
Smad     Sma- and Mad-related Protein 
SSC     Standard Saline Citrate 
Taq     thermus aquaticus  
TBE     TRIS-Borat-EDTA-Puffer 
TBS     TRIS buffered saline 
TBST    TRIS buffered saline Tween-20 
TEMED    N,N,N´,N´-tetramethyl ethylendiamine  
TGFβ    transforming growth factor beta 
Tris     tris(hydroxymethyl)aminomethan    
TUNEL     TdT-mediated dUTP-biotin nick end labelling  
U     unit 
V    Volt   
VEGF     vascular endothelial growth factor 
W     Watt 
WNT    Wingless-related integration site 
%    percent 
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